[
    {
        "pmid": "40733519",
        "title": "Cellular and Humoral Immune Profiles After Hepatitis E Vaccination and Infection.",
        "abstract": "Hepatitis E virus HEV cause significant morbidity mortality globally particularly affecting vulnerable population pregnant women HEV239 Hecolinsup®sup recombinant vaccine containing immunodominant protruding E2 domain HEV capsid protein demonstrated effectiveness yet detailed human cellular immune response remain understudied study characterized humoral cellular immune response following vaccination HEV239 natural HEV infection healthy Bangladeshi woman aged 1639 years Using dual IFNγ IL4 ELISpot assays found robust predominantly Th1mediated cellular response 30 day third vaccine dose comparable response acute infection Longitudinal antibody assessment confirmed sustained antibody production primarily E2 domain genotype 1 3 persisting two year postvaccination Despite limitation related sample size assay sensitivity finding underscore immunogenic potential HEV239 support broader use HEVendemic regions",
        "mesh_terms": [
            "Humans",
            "Hepatitis E",
            "Female",
            "Hepatitis E virus",
            "Adult",
            "Adolescent",
            "Immunity, Humoral",
            "Young Adult",
            "Immunity, Cellular",
            "Vaccination",
            "Viral Hepatitis Vaccines",
            "Bangladesh",
            "Hepatitis Antibodies",
            "Antibodies, Viral",
            "Vaccines, Synthetic",
            "Capsid Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733519/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40725984",
        "title": "The APLAR Recommendations for the Management of Psoriatic Arthritis.",
        "abstract": "auspex AsiaPacific League Associations Rheumatology APLAR aimed develop broad evidence consensusbased guideline aid health professional managing patient psoriatic arthritis PsA region working group 35 member comprising rheumatologists dermatologists patient research partner 18 APLAR country convened working group conducted systematic literature review derive quality evidence via GRADE method supporting efficacy safety class therapeutic agent management active PsA comorbidities screening specific infection concern region Recommendation statement principle management best use therapeutic drug developed Consensus within working group achieved external voting panel five 18 APLAR countries convened confirm agreement recommendation statements main literature review included 178 article clinical trial PsA Additional article evidence managing comorbidities uveitis inflammatory bowel disease screening chronic hepatitis B latent tuberculosis reviewed working group discussed reached consensus eight management principle 16 recommendation statement managing PsA Endorsement external voting panel n  90 response rate 80 achieved first recommendation management PsA patient APLAR region developed based best available evidence regionspecific consideration discussion among rheumatologists dermatologists patients strong agreement external expert panel",
        "mesh_terms": [
            "Humans",
            "Antirheumatic Agents",
            "Arthritis, Psoriatic",
            "Comorbidity",
            "Consensus",
            "Evidence-Based Medicine",
            "Rheumatology",
            "Treatment Outcome",
            "Systematic Reviews as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725984/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40725544",
        "title": "The Angiography Pattern of Buerger's Disease: Challenges and Recommendations.",
        "abstract": "2023 VAS international working group Buergers Disease BD recommended two diagnostic criterion based prior Delphi study definitive suspected definitive criterion history smoking typical angiography typical histopathological features three feature mandatory confirm definitive diagnosis BD conundrum iswhat feature considered typical BD angiography According review segmental occlusion infrapopliteal arteries corkscrew collateral appear continue occluded arterial segment Martorells sign bypass segmental occlusion absence atherosclerotic plaque aneurysm could differentiate BD ASO Hence typical BD angiography manifestation certainly considered However data differentiating angiography pattern BD small mediumsized vasculitis including Behcets disease scleroderma hepatitis associated vasculitis antiphospholipid syndrome limited study investigating angiography pattern BD patient early late presentation BD particularly patient longterm follow up highly recommended",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725544/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40714039",
        "title": "Let's break it down: combating hepatitis stigma and discrimination.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714039/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40688748",
        "title": "A systematic review of the pivotal role of environmental toxicant exposure on infectious diseases in low- and middle-income countries.",
        "abstract": "objective review identify environmental toxicant linked infectious disease low middleincome country LMICs synthesizing available evidence aim summarize key findings identify research gap provide policy recommendation based association specific toxicant disease outcomes Systematic review conducted comprehensive search PubMed Scopus Web Science core collection CENTRAL the Cochrane Library identify study bacterial viral parasitic pathogenic activity search yielded 11468 studies 55 met inclusion criterion screening following standard methods consistent association found particulate matter PM25 PM10 exposure increased respiratory infection risk PM25 particularly linked increased incidence mortality disease like COVID19 tuberculosis Heavy metals including lead cadmium mercury worsen chronic infection HIVAIDS hepatitis increasing body burden inflammation review highlight air pollutants substantial impact infectious disease spread severity noting research gap pollutant including persistent organic pollutant POPs polycyclic aromatic hydrocarbon PAHs Bias assessment indicates around half study show low risk bias however potential bias noted confounding variable blinding outcome assessment systematic review emphasizes need research biological mechanism underlying association impact pollutants Findings advocate reducing environmental pollution exposure LMICs mitigate infectious disease risk",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40688748/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40678696",
        "title": "World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring.",
        "abstract": "Noncommunicable disease NCDs account 60 annual global deaths disproportionately affecting low middleincome countries trend undermines progress toward Sustainable Development Goal SDG 34 seek reduce premature mortality NCDs onethird 2030 Despite availability effective relatively affordable interventions addressing NCDs requires sustained coordinated effort robust monitoring systems Facilitybased monitoring offer dynamic alternative static surveys enabling continuous assessment healthcare quality utilization study followed systematic approach develop standardized global national NCD monitoring indicators using Donabedian model conceptual framework focused four major NCD categories hypertension cardiovascular disease CVDs diabetes chronic respiratory diseases cancers methodology included systematic scoping review inception November 2021 multiround Delphi process involving global expert assess validity feasibility proposed indicators study funded internally WHO payment participants final output consisted 81 validated indicators22 core 59 optional indicator demonstrated high feasibility relevance facilitybased monitoring NCD service delivery provide actionable metric assessing improving quality care across diverse health system settings study highlight urgent need comprehensive contextsensitive NCD monitoring frameworks proposed set indicator offer validated foundation improving NCD care delivery aligns effort achieve SDG target 34 Ongoing update local adaptation essential ensure continued relevance effectiveness study funded internally WHO",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678696/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40675253",
        "title": "Outbreak of leptospirosis caused by Leptospira wolffii with HAV coinfections in lower Assam, Northeast India in 2024: Clinical impact and public health implications.",
        "abstract": "FebruaryMarch 2024 outbreak unknown fever jaundice multiple fatality reported Goalpara District Assam India study aimed identify etiological agent responsible outbreak guide public health interventions Clinical sample 30 individual collected analyzed using serological molecular techniques Serological testing Hepatitis Virus HAV Hepatitis E Virus HEV Leptospira performed using IgM ELISA kits Leptospira DNA extracted amplified using PCR targeting 16S rRNA gene followed nextgeneration sequencing NGS analysis result revealed HAV IgM antibody 2333  case 730 40  1230 tested positive Leptospiraspecific IgM ELISA Additionally PCR targeting 16S rRNA gene confirmed Leptospira DNA 5333  urine sample 815 Notably 1667  530 case exhibited coinfection HAV Leptospira spp challenging clinical outcome Sequencing phylogenetic analysis PCRpositive sample identified Leptospira wolffii L wolffii causative agent marking first report L wolffii human clinical sample Northeastern India Recently L wolffii member P2 subclade Leptospira garnered attention due pathogenic potential finding along reported fatalities emphasize pathogenic potential L wolffii likely introduction region via crossborder transmission neighboring Bangladesh strain prevalent study highlight need enhanced surveillance research monitor emerging Leptospira strains particularly L wolffii human animal populations better understand epidemiology pathogenicity public health implications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40675253/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40583684",
        "title": "Patterns of Presentation of Hepatocellular Carcinoma in a Tertiary Care Hospital in Bangladesh.",
        "abstract": "Hepatocellular carcinoma common primary liver cancer Chronic viral hepatitis alcohol abuse NAFLD common cause hepatocellular carcinoma Usually patient present advanced stage curative treatment longer possible study aimed find clinical presentation etiology stage presentation among patient hepatocellular carcinoma tertiary care center retrospective observational study conducted single tertiary care center July 2023 June 2024 study done among inpatient Department Hepatology 30 Cases recorded confirmed hepatocellular carcinoma period Among 30 patients 5333 patient 60 year age 7666 HBsAg positive 900 patient symptomatic among abdominal pain common Features cirrhosis hepatomegaly main physical findings Normal alphafetoprotein level 1333 patients 9666 patient advanced age curative treatment feasible Hepatocellular carcinoma significant concern crucial identify highrisk patients lead screening using serum alphafetoprotein level ultrasonography liver urgent need discover effective treatment method managing condition particularly advanced stages",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Hepatocellular",
            "Liver Neoplasms",
            "Male",
            "Middle Aged",
            "Female",
            "Tertiary Care Centers",
            "Retrospective Studies",
            "Bangladesh",
            "Adult",
            "Aged",
            "alpha-Fetoproteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583684/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40583660",
        "title": "Hepatitis C Seropositivity among Hospitalized Patients with Decompensated Chronic Liver Disease: An Observational Study in a Tertiary Care Hospital of Bangladesh.",
        "abstract": "Viral hepatitis due hepatitis B virus C virus HCV major contributor huge burden chronic liver disease Bangladesh study aimed investigate seroprevalence HCV among decompensated Chronic Liver Disease CLD patient admitted Sylhet MAG Osmani Medical College Hospital SOMCH Bangladesh crosssectional study conducted among 58 admitted patient SOMCH aged ≥18 year diagnosis decompensated CLD Detailed clinical data extracted hospital record physical examination immunochromatographic direct binding method used detection AntiHCV antibody mean age ±SD patient 457±133 year 860 male Seropositivity antiHCV antibody 172 predominance genotype3 Around 580 patient CLD class C ChildPugh scoring system Edema 910 testicular atrophy 810 leukonychia 720 jaundice 580 clubbing 580 palmar erythema 500 flapping tremor 430 ascites 400 common presentation patients HCV infection contributed almost onefifth decompensated CLD hospitaladmitted patients Mass screening adequate preventive measure recommended mitigate burden HCVinduced CLD",
        "mesh_terms": [
            "Adult",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Hepacivirus",
            "Hepatitis C",
            "Hepatitis C Antibodies",
            "Hospitalization",
            "Seroepidemiologic Studies",
            "Tertiary Care Centers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583660/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40534895",
        "title": "Improving Hepatitis B outcome prediction with ensemble machine learning: A study on predictive models and interpretability.",
        "abstract": "Hepatitis B virus HBV significant global health threat responsible severe liver disease liver failure cirrhosis hepatocellular carcinoma burden especially high lowincome regions early diagnosis treatment critical mitigating impact study investigates effectiveness various machine learning ML technique predicting patient outcome HBV infection Chisquared test used feature selection find important factors later applied train evaluate various ML models address class imbalance dataset Synthetic Minority Oversampling Technique SMOTE used balance data SHapley Additive exPlanations SHAP Local Interpretable Modelagnostic Explanations LIME used improve models interpretability Among individual models Support Vector Machine SVM Logistic Regression LR achieved accuracy 925 implementing Voting Classifier combined SVM LR overall accuracy improved 95 result showed higher level risk factors especially older patients greatly raise risk death insight provide healthcare professional policymakers valuable information develop predicting better patient outcome HBV infection patient care strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40534895/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40532465",
        "title": "Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia.",
        "abstract": "Newborns infected Hepatitis B Virus HBV risk chronic liver disease hepatocellular carcinoma study investigated prevalence HBV infection among pregnant woman cord blood Hepatitis B surface antigen HBsAg positivity newborn Bangladesh Bhutan India Ethiopia Mozambique Kenya Nigeria Mali South Africa Randomly selected paired maternal cord blood sample n  101 site taken delivery tested HBsAg Hepatitis B extractable antigen HBeAg woman using chemiluminescent microparticle immunoassay Similarly cord blood sample newborn assessed HBsAg reactivity HBV DNA quantified using Xpert® HBV viral load assay followed genotyping overall prevalence maternal HBsAg positivity 55  95 CI 04 71  n  50909 HBsAg positivity higher African country 73  95 CI 54 96  n  44606 compared South Asian country 20  95 CI 08 43  n  6303 p  0002 Relative South Africa higher odds HBsAg seropositivity woman Mozambique aOR 77 95 CI 16 378  Mali aOR 57 95 CI 11 297  rate HBsAg positivity cord blood baby born HBsAg positive woman 280  95 CI 171 423  n  1450 including 318  95 CI 195474  n  1444 African countries cord blood HBsAg positivity observed South Asia Genotypic analysis revealed HBV genotype 417  E 583  predominant high rate cord blood positivity 280  HBsAg underscore urgency enhancing HBV prevention strategy meet World Health Organizations target 90  reduction new HBV infection 2030",
        "mesh_terms": [
            "Humans",
            "Female",
            "Hepatitis B Surface Antigens",
            "Pregnancy",
            "Fetal Blood",
            "Prevalence",
            "Infant, Newborn",
            "Hepatitis B",
            "Adult",
            "Hepatitis B virus",
            "Pregnancy Complications, Infectious",
            "Young Adult",
            "DNA, Viral",
            "Africa South of the Sahara",
            "Asia",
            "Genotype",
            "Viral Load",
            "Infectious Disease Transmission, Vertical",
            "Adolescent",
            "Hepatitis B e Antigens",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40532465/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40483733",
        "title": "Synergistic effects of peptide mimics against enveloped viruses.",
        "abstract": "global health impact virus highlight urgent need innovative antiviral strategies study investigated synergistic potential two anthranilamidebased peptide mimic RK610 RK758 combination one peptide mimic RK610 combination cationic peptide Mel4 melimine murine hepatitis virus a coronavirus MHV1 influenza virus H1N1 Herpes simplex virus HSV1 Checkerboard assay demonstrated RK610RK758 synergy MHV1 H1N1 ∑FICI value 014 05 respectively RK610Mel4 showed potent synergy HSV1 ∑FICI  018 Cotreatment outperformed sequential application Transmission electron microscopy confirmed structural damage virions cytotoxicity assay indicated tested combination nontoxic MDCK A9 Vero cells except melimine RK610melimine A9 cells Biophysical analysis using DOPC 100  DOPC POPS 7030 lipid provided mechanistic idea peptidemimic interaction lipid envelopes Tethered bilayer lipid membrane tBLMs conjunction electrical impedance spectroscopy revealed peptide mimic combination reduced membrane conductance regardless lipid composition Quartz crystal microbalance dissipation monitoring QCMD revealed RK610 RK758 induced mass addition outer layer significantly increasing POPS DOPC RK610 increased surface pressure LangmuirBlodgett trough RK758 reduced it 610  758 610Mel4 combination raised maximum pressures DOPC  POPS RK758 destabilized monolayer 35 mNm plateau whereas combination restored stability finding highlight peptide mimic broadspectrum antiviral agent show synergy target viral envelopes paving way safer lowresistance therapeutics",
        "mesh_terms": [
            "Animals",
            "Antiviral Agents",
            "Peptides",
            "Influenza A Virus, H1N1 Subtype",
            "Chlorocebus aethiops",
            "Drug Synergism",
            "Dogs",
            "Vero Cells",
            "Murine hepatitis virus",
            "Cell Line",
            "Herpesvirus 1, Human",
            "Mice",
            "Madin Darby Canine Kidney Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40483733/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40318686",
        "title": "Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study.",
        "abstract": "Hepatitis C virus HCV infection significant public health concern Limited data shown unusually high HCV seroprevalence among Rohingya refugee residing camp Coxs Bazar Bangladesh aimed assess prevalence HCV seropositivity active infection identify risk factor inform HCV response crosssectional survey conducted May 10 June 14 2023 adult ≥18 years resident seven camp Coxs Bazar Households selected simple random geosampling one participant per household selected random Participants screened HCV antibody rapid finger prick blood test and seropositive venous sample tested HCV viral load structured questionnaire collected information demographics HCV knowledge exposure risks Surveyadjusted prevalence estimate HCV seropositivity active infection generated applying sampling weights Factors associated HCV seropositivity identified using univariable multivariable current status analysis associated active infection via logistic regression survey included 641 participants 425 66 woman median age 34 year IQR 2846 191 individual tested positive HCV antibodies 187 individual tested active infection 124 detectable HCV viral load surveyadjusted prevalence estimate HCV seropositivity 30·4 95 CI 26·534·5 active infection 19·8 95 CI 16·523·4 Current status analysis identified higher odds HCV seropositivity among individual reporting medical injections adjusted odds ratio 1·8 95 CI 1·22·8 surgery 5·9 1·918·4 among woman 2·1 1·33·2 328 51 641 participant never heard hepatitis C Five 4 124 participant HCV viraemia reported previous HCV treatment substantial burden active HCV infection among adult Rohingya camp residents highlighting urgent need scale testing treatment capacities survey constraint identifying risk factor could provide data HCV incidence Reassessing infection prevalence mass intervention prospective surveillance recommended monitor ongoing transmission wellconcerted multistakeholder action plan needed prevent future largescale burden severe liver disease halt ongoing transmission Médecins Sans Frontières",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Female",
            "Bangladesh",
            "Male",
            "Adult",
            "Refugees",
            "Hepatitis C",
            "Prevalence",
            "Middle Aged",
            "Seroepidemiologic Studies",
            "Risk Factors",
            "Hepacivirus",
            "Hepatitis C Antibodies",
            "Young Adult",
            "Viral Load",
            "Adolescent",
            "Refugee Camps",
            "Myanmar"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40318686/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40295852",
        "title": "Effects of oxidative stress on viral infections: an overview.",
        "abstract": "Viral infection trigger increased reactive oxygen specie ROS production reduced antioxidant response host leading redox stress inflammation apoptosis ultimately cell tissue damage contribute disease development better understanding ROS contributes viral pathogenesis critical development novel therapeutic interventions review discus current knowledge ROS production effect across various viral infections including severe acute respiratory syndromecoronavirus2 influenza virus dengue virus Zika virus hepatitis B virus hepatitis C virus human immunodeficiency virus infections improve future therapeutic preventive strategy infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40295852/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40190944",
        "title": "Duodenal Amyloidosis Inducing Malabsorption in Hepatitis B-Related Liver Cirrhosis: A Rare Case Presentation.",
        "abstract": "Chronic hepatitis B virus HBV infection major cause liver cirrhosis worldwide hepatic complication welldocumented extrahepatic manifestation secondary amyloidosis less common lead diverse complex clinical outcomes Here present case 60yearold male history chronic hepatitis B progressed liver cirrhosis presented chronic unexplained intractable diarrhea unresponsive standard treatments also experienced significant unintentional weight loss generalized weakness investigation revealed amyloid deposition duodenum confirming secondary amyloidosis affecting gastrointestinal tract cause malabsorption Persistent diarrhea malabsorption necessitated nutritional support symptomatic management case highlight rare association chronic liver disease CLD secondary amyloidosis malabsorption syndrome emphasizing importance clinical suspicion timely diagnosis Early recognition prompt intervention crucial managing complex cases improving outcomes preventing complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40190944/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40173410",
        "title": "Enlightened prognosis: Hepatitis prediction with an explainable machine learning approach.",
        "abstract": "Hepatitis widespread inflammatory condition liver presenting formidable global health challenge Accurate timely detection hepatitis crucial effective patient management yet existing method exhibit limitation underscore need innovative approaches Earlystage detection hepatitis possible recent adoption machine learning deep learning approaches mind study investigates use traditional machine learning models specifically classifier logistic regression support vector machine SVM decision trees random forest multilayer perceptron MLP models predict hepatitis infections extensive data preprocessing including outlier detection dataset balancing feature engineering evaluated performance models explored three modeling approaches machine learning default hyperparameters hyperparametertuned model using GridSearchCV ensemble modeling techniques SVM model demonstrated outstanding performance achieving 9925 accuracy perfect AUC score 100 consistency metric 9927 precision 9924 recall F1measure MLP Random Forest proved pace superior performance SVM exhibiting accuracy 9900 ensure robustness employed 5fold crossvalidation technique deeper insight model interpretability validation employed explainability analysis bestperformed model identify effective feature hepatitis detection proposed model particularly SVM exhibit better prediction performance regarding different performance metric compared existing literature",
        "mesh_terms": [
            "Humans",
            "Prognosis",
            "Machine Learning",
            "Support Vector Machine",
            "Hepatitis",
            "Decision Trees",
            "Logistic Models"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40173410/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40161035",
        "title": "Unmasking the Duo: Wilson's Disease in the Context of Lupus and Existing Hepatitis E Coinfection.",
        "abstract": "report case 19yearold woman presented plethora overlapping symptom complex etiology final diagnosis concurrent Wilsons disease background Systemic Lupus Erythematosus Hepatitis E infection affect similar organ lead presentation jaundice fever neuropsychiatric symptoms personality changes unique case manifestation symptom specifically related Wilsons disease bizarre behavior initial mutism followed irrelevant speech SLE symptom present oral ulcers alopecia arthralgia affecting small joint hand foot along palpitation shortness breath key clinical message need thorough diagnostic evaluation WD masked mistaken autoimmune conditions SLE early identification treatment condition crucial preventing disease progression improving patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40161035/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40131873",
        "title": "Low Hepatitis B vaccination rates among medical students in South Asia: A systematic review and meta-analysis.",
        "abstract": "Current future healthcare professionals medical students risk contracting Hepatitis B virus infection Vaccination Hepatitis B effective mean prevention However study reported variable vaccination rate among medical student different region South Asia Understanding vaccination rate barrier guide effective intervention protect future doctors Therefore aimed find vaccination rate among medical student South Asia comprehensive literature search conducted across multiple database PubMed PubMed Central Scopus Embase CINAHL Google Scholar MEDLINE sources beginning inception July 15 2024 Observational study reporting vaccination rate among Bachelor Medicine Bachelor Surgery MBBS student South Asia included Two reviewer independently screened performed quality assessment Pooled vaccination rate calculated visualized using randomeffects model R Studio Version 2023120 Subgroup analysis performed based country year publication studies Fifty study South Asian region including 12231 participants included quantitative analysis overall pooled Hepatitis B vaccination rate using randomeffects model 56 CI 4963 significant heterogeneity among included study I2  98 P  0 Subgroup analysis based country revealed significant regional variation vaccination rate 59 Pakistan 57 India 55 Nepal 41 Bangladesh P  001 Lack awareness perceived low risk necessity concern side effects logistical challenges lack motivation reported barrier vaccination overall vaccination rate relatively low South Asia significant regional variation Based reported barriers recommend relevant authority focus vaccination awareness motivation costeffectiveness logistics management policy formulation monitoring",
        "mesh_terms": [
            "Humans",
            "Students, Medical",
            "Hepatitis B",
            "Vaccination",
            "Hepatitis B Vaccines",
            "Asia",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40131873/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40107226",
        "title": "Burden of acute hepatitis E virus in South Asia: Insights from Global Burden of Disease study 2021.",
        "abstract": "Despite global progress South Asian country account disproportionate burden Acute hepatitis E AHE Understanding burden AHE region crucial targeted interventions used Global Burden Disease GBD 2021 data assess burden AHE across eight South Asian country 1990 2021 Joinpoint regression used analyze temporal trend Estimated Annual Percentage Change EAPC calculated quantify trends relationship agestandardized disabilityadjusted life year rate ASDR sociodemographic index SDI assessed using smoothing spline model Spearman rank correlation Rates expressed per 100000 population Bangladesh highest agestandardized prevalence rate ASPR 3327 95  Uncertainty Interval 2764 3995 agestandardized incidence rate ASIR 43301 35961 51976 India highest ASDR 952 433 1842 Males higher ASIR ASPR female South Asian countries except Bhutan India higher ASDR except Nepal Pakistan Bhutan highest EAPC sex ASPR ASIR India highest EAPC ASDR closely followed Bhutan sexes Age group 59 highest ASPR ASIR whereas 1year age group highest ASDR inverse relationship ASDR SDI R  049 p  001 South Asia bear high burden AHE variation across countries Improvements Water Sanitation Hygiene WASH service needed achieve Sustainable Development Goals 3 6",
        "mesh_terms": [
            "Humans",
            "Hepatitis E",
            "Male",
            "Female",
            "Global Burden of Disease",
            "Adult",
            "Prevalence",
            "Middle Aged",
            "Asia",
            "Adolescent",
            "Disability-Adjusted Life Years",
            "Young Adult",
            "Incidence",
            "Child, Preschool",
            "Child",
            "Infant",
            "Hepatitis E virus",
            "Aged",
            "Cost of Illness",
            "Acute Disease",
            "Infant, Newborn",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40107226/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40102552",
        "title": "Distinct phylogeographic distributions and frequencies of precore and basal core promoter mutations between HBV subgenotype C1 rt269L and rt269I types.",
        "abstract": "Hepatitis B virus HBV genotype C exhibit two distinct polymorphism viral polymerase rt269I rt269L Recently reported distinct virological clinical profile chronic patient subgenotype C2 rt269I polymorphism rt269L polymorphism latter closely related liver disease severity study explored phylogenetic geographic distributions well mutation frequencies precore T1858CG1896A basal core promoter BCP A1762TG1764A mutation two type within HBV subgenotype C1 Analysis 408 HBVC1 fullgenome sequence GenBank revealed clear phylogenetic separation rt269L rt269I subgenotype C1 Geographically rt269I strain within subgenotype C1 predominant Southwest Asia eg Thailand Bangladesh whereas rt269L strain common East Asia Southeast Asia eg Vietnam China Hong Kong Notably compared rt269L subgenotype C2 rt269I presented higher frequency C1858 BCP mutation lower frequency G1896A mutation finding suggest significantly distinct phylogeographic mutational characteristic rt269L rt269I type subgenotype C1 impacting clinical outcome evolutionary trajectories",
        "mesh_terms": [
            "Hepatitis B virus",
            "Humans",
            "Promoter Regions, Genetic",
            "Phylogeography",
            "Genotype",
            "Mutation",
            "Phylogeny",
            "Hepatitis B, Chronic",
            "Genome, Viral",
            "Male",
            "Hepatitis B"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40102552/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40080680",
        "title": "Population-Based Estimates of Hepatitis E Virus-Associated Mortality in Bangladesh.",
        "abstract": "Hepatitis E virus HEV endemic many resourcepoor countries Despite available vaccine data HEVassociated mortality scarce hindering informed decisions study aim estimate populationbased rate HEVspecific mortality Bangladesh December 2014 September 2017 conducted surveillance 6 tertiary hospital Bangladesh Patients aged ≥14 year acute jaundice recruited tested IgM antiHEV followed postdischarge mortality survey hospital catchment area identified death associated acute jaundice including maternal deaths stillbirths neonatal death delivered mother acute jaundice pregnancy confirmed 2 independent physician reviewing verbal autopsy data 1925 patient acute jaundice enrolled surveillance hospitals 302 died 28 9 testing positive IgM antiHEV hospital catchment areas team identified 587 jaundiceassociated deaths including 25 maternal deaths Combining hospitalbased surveillance mortality survey data study estimated 986 95 CI 5991338 HEVassociated death annually among individual aged ≥14 year Bangladesh including 163 95 CI 57395 maternal deaths Additionally 279 95 CI 101664 stillbirth 780 95 CI 3651297 neonatal death attributed HEV infection annually Prior Global Burden Disease study presented wildly varying modeling estimate HEVassociated annual deaths ranging 50 000 2013 1932 2019 study first directly measure populationbased estimate mortality Bangladesh used determine costeffectiveness hepatitis E vaccination interventions",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Hepatitis E",
            "Female",
            "Adult",
            "Hepatitis E virus",
            "Male",
            "Young Adult",
            "Adolescent",
            "Middle Aged",
            "Pregnancy",
            "Immunoglobulin M",
            "Infant, Newborn",
            "Jaundice",
            "Infant",
            "Hepatitis Antibodies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40080680/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40076932",
        "title": "Characterization of Exhausted T Cell Signatures in Pan-Cancer Settings.",
        "abstract": "cell play diverse role cancer immunology acting tumor suppressors cytotoxic effectors enhancer cytotoxic lymphocyte response immune suppressors providing memory surveillance modulating tumor microenvironment TME activating innate immune cells However cancer cell disrupt cell function leading cell exhaustion weakened immune response tumor expression exhausted cell Tex marker play pivotal role shaping immune landscape multiple cancers aim systematically investigate role known cell exhaustion Tex marker across multiple cancer exploring molecular interactions mutation profiles potential implication immunotherapy mRNA expression profile six Tex markers iLAG3i iPDCD1i iTIGITi iHAVCR2i iCXCL13i iLAYNi investigated pancancer Utilizing data Cancer Genome Atlas TCGA Gene Expression Omnibus GEO Cancer Proteome Atlas TCPA repositories characterized differential expression Tex markers association patients survival outcome mutation profile multiple cancers Additionally analyzed effect cancerrelated pathway immune infiltration within TME offering valuable insight mechanism cancer immune evasion progression Finally correlation expression sensitivity multiple anticancer drug investigated extensively Differential expression six marker significantly associated KIRC poor prognosis several cancers also played potential activating role apoptosis EMT hormone ER pathways well potential inhibitory role DNA damage response RTK oncogenic pathways Infiltration different immune cell also found associated expression Texrelated gene cancer types finding underline reviving exhausted cell used enhance efficacy immunotherapy cancer patients",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Tumor Microenvironment",
            "T-Lymphocytes",
            "Biomarkers, Tumor",
            "Gene Expression Regulation, Neoplastic",
            "Lymphocyte Activation Gene 3 Protein",
            "Mutation",
            "Programmed Cell Death 1 Receptor",
            "Hepatitis A Virus Cellular Receptor 2",
            "Antigens, CD",
            "Receptors, Immunologic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40076932/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40062742",
        "title": "Global Burden of Major Chronic Liver Diseases in 2021.",
        "abstract": "study utilised Global Burden Disease data 20102021 analyse rate trend point prevalence annual incidence year lived disability YLDs major chronic liver diseases hepatitis B hepatitis C metabolic dysfunctionassociated liver disease cirrhosis chronic liver diseases Agestandardised rate per 100000 population prevalence annual incidence YLDs compared across region countries well sociodemographic index SDI Trends expressed percentage change PC estimate reported uncertainty interval UI Globally 2021 agestandardised rate per 100000 population prevalence hepatitis B hepatitis C MASLD cirrhosis chronic liver disease 35836 95UI 3293638877 17178 1385520753 150181 137565163614 203026 188452217919 respectively 2010 2021 PC agestandardised prevalence rate were204 hepatitis B 51 hepatitis C 112 MASLD  26 cirrhosis chronic liver diseases period PC agestandardized incidence rate 247 68 32 30 respectively Generally negative associations fluctuations found agestandardised prevalence rate hepatitis B hepatitis C cirrhosis chronic liver disease SDI global level However MASLD prevalence peaked moderate SDI levels global burden chronic liver disease remains substantial Hepatitis B C decreased prevalence incidence last decade MASLD cirrhosis chronic liver disease increased necessitating targeted public health strategy resource allocation",
        "mesh_terms": [
            "Humans",
            "Global Burden of Disease",
            "Prevalence",
            "Incidence",
            "Male",
            "Middle Aged",
            "Female",
            "Adult",
            "Global Health",
            "Liver Diseases",
            "Liver Cirrhosis",
            "Chronic Disease",
            "Aged",
            "Young Adult",
            "Hepatitis C, Chronic",
            "Hepatitis B, Chronic",
            "Disability-Adjusted Life Years",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40062742/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40051950",
        "title": "Unmasking Portal Colopathy: A Case of Rectal Bleeding in a Patient With Liver Cirrhosis Misdiagnosed as Ulcerative Colitis.",
        "abstract": "report outline diagnostic journey 31yearold female patient chronic hepatitis B virus HBV infection presented acute rectal bleeding Initially misdiagnosed ulcerative colitis primary care center though underlying cause symptom related cirrhosis complication portal hypertensive colopathy PHC presentation revealed history ascites month onset rectal bleeding managed diuretics Subsequent investigation led revised diagnosis decompensated cirrhosis secondary chronic HBV infection PHC identified cause rectal bleeding case highlight diagnostic challenge faced managing patient coexisting cirrhosis gastrointestinal bleeding initially misdiagnosed ulcerative colitis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40051950/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40016576",
        "title": "The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.",
        "abstract": "Metabolic dysfunctionassociated fatty liver disease MAFLD affect onefourth global adult population leading cause liver disease worldwide address this Asian Pacific Association Study Liver APASL created clinical practice guideline focused MAFLD guideline cover various aspect disease epidemiology diagnosis screening assessment treatment guideline aim advance clinical practice knowledge research MAFLD particularly special groups guideline designed advance clinical practice provide evidencebased recommendation assist healthcare stakeholder decisionmaking improve patient care disease awareness guideline take account burden clinical management healthcare sector",
        "mesh_terms": [
            "Humans",
            "Fatty Liver",
            "Non-alcoholic Fatty Liver Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40016576/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39988206",
        "title": "Adeno-associated virus 2 CRISPR/Cas9-mediated targeting of hepatitis B virus in tree shrews.",
        "abstract": "Chronic hepatitis B virus HBV infection global health issue limited therapeutic option given persistence viral episomal DNA cccDNA Previously investigated effect adenoassociated virus 2 AAV2 vectormediated delivery three guide gRNAsCas9 selected 16 gRNAs AAV2WJ11Cas9 effectively suppressed HBV replication vitro humanized chimeric mouse livers present study examined effect AAV2WJ11Cas9 acute phase HBV genotype F infection immunocompetent northern tree shrew Tupaia belangeri hereafter tupaia model AAV2WJ11Cas9 treatment significantly reduced HBV viral load serum 1 7 10 14 day postinfection dpi HBVF infection caused enlargement hepatocytes mild lymphocytic infiltration interlobular connective tissue Thus virus damage hepatocytes drive infection progression HBV core antigen HBcAg accumulation observed AAV2WJ11Cas9 treated normal liver tissues AAV2WJ11Cas9 treatment reduced HBV DNA cccDNA liver tissues well serum level HBV surface antigen HBV corerelated antigen HBcrAg including HBcAg HBeAg 14 dpi AntiHBc antiHBs antiAAV Abs production also detected AAV2WJ11Cas9 treatment suppressed inflammatory cytokine TLR1 TLR2 TLR3 TLR4 TLR6 TLR7 TLR9 mRNA levels Thus WJ11Cas9 delivered AAV2 vector may provide new therapeutic approach inhibiting HBV infection immunocompetent animal models could developed use human translational research",
        "mesh_terms": [
            "Animals",
            "Hepatitis B virus",
            "Dependovirus",
            "CRISPR-Cas Systems",
            "Liver",
            "Disease Models, Animal",
            "Virus Replication",
            "Tupaiidae",
            "Hepatitis B",
            "Viral Load",
            "Hepatocytes",
            "Tupaia",
            "Humans",
            "Hepatitis B, Chronic",
            "Genetic Vectors",
            "Hepatitis B Core Antigens",
            "DNA, Viral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39988206/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39961976",
        "title": "Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.",
        "abstract": "Acuteonchronic liver failure ACLF condition associated high mortality absence liver transplantation various definition proposed worldwide first consensus report working party Asian Pacific Association Study Liver APASL set 2004 ACLF published 2009 APASL ACLF Research Consortium AARC formed 2012 AARC database prospectively collected nearly 10500 case ACLF various country AsiaPacific region database instrumental developing AARC score grade ACLF concept Golden Therapeutic Window transplant window plasmapheresis treatment modality Also data key identifying pediatric ACLF European Association Study LiverChronic Liver Failure EASL CLIF North American Association Study End Stage Liver Disease NACSELD West added concept organ failure infection precipitant development ACLF CLIFSequential Organ Failure Assessment SOFA NACSELD score prognostication Chinese Group Study Severe Hepatitis B COSSH added COSSHACLF criterion manage hepatitis b virusACLF without cirrhosis literature support definition equally effective respective cohort identifying patient high mortality overcome difference develop global consensus APASL took initiative invited global stakeholders including opinion leader Asia EASL AASLD researcher field ACLF identify key issue develop evidencebased consensus document consensus document presented hybrid format APASL annual meeting Kyoto March 2024 Kyoto APASL Consensus presented carry final recommendation along relevant background information area requiring future studies",
        "mesh_terms": [
            "Acute-On-Chronic Liver Failure",
            "Humans",
            "Asia",
            "Consensus",
            "Organ Dysfunction Scores",
            "Liver Transplantation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39961976/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39940455",
        "title": "Thyroid Stimulatory Activity of <i>Houttuynia cordata</i> Thunb. Ethanolic Extract in 6-Propyl-Thiouracil-Induced Hypothyroid and STZ Induced Diabetes Rats: In Vivo and In Silico Studies.",
        "abstract": "iHouttuynia cordatai Thunb hold longstanding reputation traditional folk remedy East Asia employed treat variety inflammatory conditions nephritis hepatitis cancer Despite extensive use exists paucity research examining efficacy managing thyroid disorder diabetes Moreover bioactive component responsible modulating molecular pathway remain elusive research aimed determine key bioactive component ethanolic extract iH cordatai Thunb HCEE responsible thyroidmodifying property examine effect rat experimentally induced hypothyroidism diabetes Molecular docking performed investigate possible mechanism thyroid regulation HCEE constituents Researchers induced hypothyroidism rat adding 6propyl2thiouracil drinking water period four weeks induce diabetes rat received intraperitoneal injection streptozotocin animal given daily oral dos HCEE 500 mgkg bw levothyroxine 50 mgkg bw glibenclamide 5 mgkg bw 28 days Following treatment standard method employed measure biochemical parameter rats serum result demonstrate HCEE ameliorated hypothyroidism increasing serum T3 1438 T4 12596 level decreasing TSH ipi  001 4175 levels diabetic rat induced hypothyroidism HCEE significantly ipi  0001 increased T3 14951 T4 7354 level reduced TSH 6439 levels silico analysis demonstrated identified bioactive compound HCEE may enhance thyroid hormone function interaction thyroid hormone receptor protein TRβ1 PDB3GWS similar conventional pharmaceutical levothyroxine triiodothyronine T3 HCEE exhibit potential natural alternative synthetic medication prevention treatment thyroid dysfunctions",
        "mesh_terms": [
            "Animals",
            "Hypothyroidism",
            "Diabetes Mellitus, Experimental",
            "Thyroid Gland",
            "Molecular Docking Simulation",
            "Rats",
            "Houttuynia",
            "Male",
            "Propylthiouracil",
            "Plant Extracts",
            "Ethanol",
            "Streptozocin",
            "Computer Simulation",
            "Rats, Sprague-Dawley",
            "Thyroxine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39940455/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39820842",
        "title": "Machine learning and spatio-temporal analysis of meteorological factors on waterborne diseases in Bangladesh.",
        "abstract": "Bangladesh facing formidable challenge mitigating waterborne disease risk exacerbated climate change However comprehensive understanding spatiotemporal dynamic disease district level remains elusive Therefore study aimed fill gap investigating spatiotemporal pattern identifying best treebased ML model determining meteorological factor associated waterborne disease Bangladesh study used districtlevel reported case waterborne disease cholera amoebiasis typhoid hepatitis A obtained Bangladesh Bureau Statistics BBS meteorological data temperature relative humidity wind speed precipitation sourced NASA period spanning 2017 2020 Exploratory spatial analysis spatial regression treebased machine learning model utilized analyze data 2017 2020 Bangladesh reported 73 606 cholera 38 472 typhoid 2 510 hepatitis 1 643 amoebiasis disease cases Among waterborne disease cholera showed higher incidence rate ChapaiNawabganj 45623 Brahmanbaria 41744 Faridpur 22507 Nilphamari 18862 Pirojpur 17162 districts spatial regression model identified mean temperature β  1216 se 391 significant risk factor waterborne diseases optimal XGBoost model highlighted mean minimum temperature relative humidity precipitation determinant associated waterborne disease Bangladesh 2017 2020 finding study incorporating One Health perspective provide insight planning early warning prevention control strategy combat waterborne disease Bangladesh similar endemic countries Precautionary measure intensified surveillance need implemented certain highrisk district waterborne disease across country",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Machine Learning",
            "Spatio-Temporal Analysis",
            "Meteorological Concepts",
            "Waterborne Diseases",
            "Cholera",
            "Typhoid Fever",
            "Incidence",
            "Temperature"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39820842/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39802853",
        "title": "HeberNasvac: Development and Application in the Context of Chronic Hepatitis B.",
        "abstract": "immune system play central role controlling acute hepatitis B infection patient resolving chronic hepatitis B CHB Given 221 million 75 CHB patient reside low middleincome countries development vaccine therapeutic property represents rational costeffective approach romantic endeavor review systematically analyzes key variable related safety efficacy effectiveness CHB treatments HeberNasvac experience revisited addressing challenge potentiality therapeutic vaccines well current roadblock research development registration largescale implementation Aguilar JC Akbar SMF AlMahtab M iet ali HeberNasvac Development Application Context Chronic Hepatitis B Euroasian J HepatoGastroenterol 2024142221237",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39802853/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39781299",
        "title": "Training of medical coordinators for noncommunicable diseases based on Japanese experience.",
        "abstract": "incidence noncommunicable disease NCDs increasing low middleincome country represents major public health challenge Herein present Japans experience training medical coordinator combat NCDs focus hepatitis earlyonset dementia child medical complexity Coordinators play important role bridging gap patient healthcare services examined training role coordinators Japanese model medical coordinators including medical nonmedical personnel successfully strengthened delivery healthcare service specific diseases However challenge persist including uneven distribution coordinators inconsistency training programs programs relatively recent establishment limited awareness coordinators role activities Training medical coordinator strengthen comprehensive patient support managing NCDs Despite limitations model provides valuable insight developing interventional strategy Asian country facing similar medical human resource shortages Collaboration among governments hospitals related organisation training coordinator hold promise addressing growing prevalence NCDs regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39781299/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39739489",
        "title": "Serum Vitamin D Status in Infants with Cholestatic Jaundice.",
        "abstract": "Cholestatic jaundice potentially serious condition requires early diagnosis proper management Fatsoluble vitamin FSV deficiency develops consequence cholestasis Vitamin deficiency common remains challenge patient cholestasis Objectives study evaluate serum 25hydroxyvitamin status infant cholestatic jaundice crosssectional analytical study conducted department Paediatric Gastroenterology Nutrition Bangabandhu Sheikh Mujib Medical University Dhaka Bangladesh January 2017 June 2018 purposively sampled infants Infants developed jaundice three month age direct bilirubin 200 total bilirubin total bilirubin ≥5 mgdl 10 mgdl total bilirubin 5 mgdl pale stool dark urine included case infant visited hospital diagnosis acute bronchiolitis reactive airway disease acute viral infection evidence liver gastrointestinal disease renal disease checked mean medical history physical examination review medical record included controls Blood collected patient cholestatic liver disease liver biochemistries prothrombin time 25hydroxyvitamin serum calcium Blood also collected control 25hydroxyvitamin serum calcium 25hydroxyvitamin level 15 15 20 20 ngml defined vitamin deficiency insufficiency sufficiency respectively Thirty patient 30 control evaluated Mean age case control 11343±7408 14550±8862 day respectively p0134 Biliary atresia found commonest cause 18600 followed idiopathic neonatal hepatitis INH 7233 choledochal cyst 4133 1 case neonatal hepatitis NH due CMV infection mean serum bilirubin total 1207±392 mgdl mean serum bilirubin direct 651±203 mgdl serum ALT 1307±6781 UL serum AST 13507±5254 UL prothrombin time 1736±1188 seconds serum gammaglutamyl transpeptidase GGT 7003±55589 UL alkaline phosphatase 56037±28312 UL serum albumin 36±04 gmdl Mean serum calcium 918±084 mgdl Mean 25hydroxyvitamin level cholestatic patient 147±575 ngml compared 2768±1044 ngml control p0001 Vitamin deficiency found 433 patients correlation age presentation serum 25hydroxyvitamin level significant r  0051 p  0784 Statistically significant negative correlation r  0389 p0034 found serum 25hydroxyvitamin serum gammaglutamyl transpeptidase Serum calcium found statistically significant positive correlation 25hydroxyvitamin r0692 p0001 Blood level 25hydroxyvitamin patient cholestasis lower controls So adequate vitamin supplementation monitoring population great importance",
        "mesh_terms": [
            "Humans",
            "Infant",
            "Vitamin D",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Vitamin D Deficiency",
            "Jaundice, Obstructive",
            "Bangladesh",
            "Infant, Newborn",
            "Cholestasis",
            "Bilirubin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39739489/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39585861",
        "title": "Knowledge, attitude, and practice towards Hepatitis B and vaccination status of pre-clinical medical students at Sylhet Women's Medical College, Bangladesh.",
        "abstract": "Hepatitis B global health problem high morbidity mortality risk transmission common among health care personnel medical student professional health trainings Vaccination effective mean prevention main objective study determine level knowledge attitude practice regarding Hepatitis B vaccination among preclinical student medical college webbased singlecenter descriptive crosssectional study conducted among preclinical medical student Bangladesh April 28 2024 May 4 2024 whole sampling technique method used taking entire population study Data collected using selfadministered questionnaire analyzed using JMP Pro V17 Statistical Software Sixtyone 34 student vaccinated Hepatitis B 18 received three dos booster dose common reason nonvaccination lack awareness ones vaccination status 43 median knowledge attitude practice KAP score 54 5060 19 1721 20 1923 respectively moderately positively correlated Fortysix 2598 student good overall KAP score ≥ 102 onethird student vaccinated commonest reason nonvaccination lack awareness ones vaccination status Nearly onefourth participant good knowledge attitude practice related Hepatitis B Therefore education regarding Hepatitis B infection risk factors importance vaccination must among preclinical medical student Bangladesh",
        "mesh_terms": [
            "Humans",
            "Students, Medical",
            "Bangladesh",
            "Female",
            "Hepatitis B",
            "Health Knowledge, Attitudes, Practice",
            "Vaccination",
            "Cross-Sectional Studies",
            "Young Adult",
            "Male",
            "Adult",
            "Surveys and Questionnaires",
            "Hepatitis B Vaccines",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39585861/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39570557",
        "title": "APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.",
        "abstract": "AsiaPacific region hepatocellular carcinoma serious health threat attributing 600000 death year account 70 global cases Clinically major unmet need recurrence curativeintent surgery liver transplantation local ablation disease progression hepatocellular carcinoma eligible resection failed locoregional therapy recent years new targeted therapy immunecheckpoint inhibitor registered systemic therapy address issues Notably new form systemic therapy either firstline secondline therapy unresectable hepatocellular eligible locoregional therapy available New data also emerging use systemic therapy prevent hepatocellular carcinoma recurrence curativeintent resection local ablation therapy retard disease progression locoregional therapy future implementation immunecheckpoint inhibitor form immunotherapy expected bring new paradigm management hepatocellular carcinoma New insight related immunerelated adverse event use immunotherapy allso enabled optimization therapeutic approach patient hepatocellular carcinoma purpose clinical practice guideline provide uptodate recommendation based clinical evidence experience expert AsiaPacific key opinion leader field hepatocellular carcinoma Three key question addressed namely 1 patient hepatocellular carcinoma considered systemic therapy 2 systemic therapy used 3 patient planned immune checkpointbased systemic therapy managed monitored",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Hepatocellular",
            "Immune Checkpoint Inhibitors",
            "Immunotherapy",
            "Liver Neoplasms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39570557/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39547254",
        "title": "It is time for World Hepatitis Testing Week.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39547254/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39543999",
        "title": "Addressing Public Health Risks: Strategies to Combat Infectious Diseases After the August 2024 Floods in Bangladesh.",
        "abstract": "August 2024 flood Bangladesh precipitated major public health crisis significantly elevating risk waterborne vectorborne disease exacerbating existing health vulnerabilities disaster impacted 5 million people causing widespread environmental disruption population displacement strained healthcare resources flooding latrines sewage systems agricultural land led contamination drinking water sources increasing risk cholera enterotoxigenic Escherichia coli diarrhoea shigellosis hepatitis Additionally stagnant floodwaters created breeding ground mosquitoes thereby increasing threat malaria dengue fever disruption healthcare service compounded crisis delaying emergency response impeding access care psychological impact affected community profound mental health issue anxiety depression posttraumatic stress disorder emerging significant concerns perspective provides analysis public health threats supported data impact flood discussion underlying risk factors underscore need immediate longterm public health interventions including restoring clean water access enhancing disease surveillance repairing healthcare infrastructure addressing mental health needs response disaster must rapid comprehensive lesson learned inform preparedness effort better manage similar event future",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Floods",
            "Public Health",
            "Risk Factors",
            "Communicable Diseases",
            "Disasters"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39543999/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39477629",
        "title": "Global multi-societies endorsement of the MAFLD definition.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39477629/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39472687",
        "title": "Clinical validation of peripheral blood mononuclear cell DNA methylation markers for accurate early detection of hepatocellular carcinoma in Asian patients.",
        "abstract": "Hepatocellular carcinoma HCC leading cause cancerrelated death globally pose significant challenge early detection Improved diagnostic accuracy drastically influence patient outcomes emphasizing need innovative noninvasive biomarkers study utilized cohort 402 participants including healthy controls chronic hepatitis patients HCC patient Bangladesh evaluate DNA methylation signature peripheral blood mononuclear cell PBMC performed targeted nextgeneration sequencing selected gene previously identified assess methylation dynamics development M8 M4 score based dynamics using Receiver Operating Characteristic ROC analysis determine effectiveness detecting earlystage HCC alongside existing marker epiLiver alphafetoprotein AFP Integration M8 M4 score epiLiver AFP significantly enhances diagnostic sensitivity earlystage HCC M4epiLiver score achieves sensitivity 794 Stage HCC combining M4 AFP increase sensitivity 882957 across stages indicating superior diagnostic performance compared marker used alone study confirms combining gene methylation profile established diagnostic marker substantially improves sensitivity detecting earlystage HCC integrated diagnostic approach hold promise advancing noninvasive cancer diagnostics potentially leading earlier treatment intervention improved survival rate highrisk patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39472687/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39424567",
        "title": "Hepatitis E vaccine and fetal loss: the potential pathophysiological basis - Authors' reply.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39424567/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39367477",
        "title": "Effective community-based interventions to prevent and control infectious diseases in urban informal settlements in low- and middle-income countries: a systematic review.",
        "abstract": "impact rapid urbanization taking place across world posing variegated challenges Especially term communicable disease risk concentrated urban poor area basic amenity inadequate systematic review synthesizes evidence effective communitybased intervention CBIs aimed preventing controlling infectious disease among urban poor low middleincome country LMICs systematic review conducted following PRISMA Preferred Reporting Items Systematic Reviews MetaAnalysis guidelines comprehensive search across five major database conducted capture literature CBIs published 2011 2021 Scientific article design reported type CBIs effective preventing controlling infectious disease tuberculosis diarrhea typhoid dengue hepatitis B C influenza COVID19 included Screening selection study done two pair independent researcher using predefined eligibility criteria risk bias included study assessed using modified checklist outlined Cochrane Handbook Systematic Reviews Interventions Effective Public Health Practice Project EPHPP Analysis effective CBIs guided conceptual framework integrated CBIs neglected tropical disease NTDs narrative synthesis carried out Geographical restriction limited LMICs paper published English 18260 identified papers 20 study met eligibility criterion included review Communitybased screening socioeconomic support communitybased vector control behavior change communication capacity building community health worker CHWs health education e mhealth intervention found effective CBIs Diversified CBIs found effective specific diseases including tuberculosis TB diarrhea dengue influenza ARI hepatitis B C Bundling intervention found effective specific diseases However difficult isolate effectiveness individual intervention within bundle sociocultural context considered designing implementing CBIs effectiveness intervention inextricably linked social context stakeholder dimensions broader societal issues System approach recommended emphasizing contextspecific multicomponent intervention address social determinant health Integrating intervention public health strategy community involvement crucial sustainable outcomes finding guide design future intervention better prevention control communicable disease urban poor areas PROSPERO CRD42021278689",
        "mesh_terms": [
            "Humans",
            "Developing Countries",
            "Communicable Disease Control",
            "COVID-19",
            "Community Health Services",
            "Communicable Diseases",
            "Urban Population",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39367477/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39319277",
        "title": "Efficacy and Safety of Valganciclovir in Congenital Cytomegalovirus Infection with Isolated Intrahepatic Cholestasis: A Randomized Controlled Trial.",
        "abstract": "Cytomegalovirus CMV infection affect hepatic neurologic hematopoietic respiratory gastrointestinal organs resulting high mortality rate longterm sequelae may cause acute chronic hepatitis even lead hepatic cirrhosis Valganciclovir VGCV effective safe welltolerated treatment congenital CMV infection without serious adverse effects study conducted evaluate clinical biochemical virological profile infant CMV intrahepatic cholestasis determine outcome without treatment VGCV Twenty infant aged 6 month diagnosed congenital CMV infection evidence intrahepatic cholestasis included study Randomization used divide study participant 2 groups control group n10 treated supportive management intervention group n10 treated oral VGCV 16 mgkgdose 12 hour day 6 week plus supportive treatments Physical examination biochemical serological virological test performed time diagnosis end 6 week 6 months control intervention group compared term clinical laboratory parameter jaundice dark urine pale stool hepatomegaly total bilirubin aminotransferases gammaglutamyl transferase alkaline phosphatase CMV polymerase chain reaction load showed significant reduction treatment intervention group ipi005 oral VGCV side effects whereas control group showed significant changes Oral VGCV used effectively treat CMV infection intrahepatic cholestasis without notable side effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39319277/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39246409",
        "title": "Regulation of Hepatitis B Virus Replication by Modulating Endoplasmic Reticulum Stress (ER-Stress).",
        "abstract": "Hepatitis B virus HBV resistant several antiviral drug due viral genomic mutations reported aggravates chronic infection lead hepatocellular carcinoma Therefore host cellular factorssignaling modulation might alternative way treatment drugresistant HBV Here investigated viral protein expression replication virion production using endoplasmic reticulum ER stressmodulating chemicals tunicamycin an ERstress inducer salubrinal an ERstress inhibitor found ERstress could induced HBV replication transfected HepG2 cell well tunicamycin demonstrated dual luciferase assay HBV intracellular coreassociated DNA quantified qPCR significantly increased tunicamycin transfected HepG2 cells Inversely intracellular core associated extracellular particle DNA significantly decreased dosedependent manner salubrinaltreated HepG2 cell transfected HBVreplicating plasmid pHBI Similar result found stably HBVexpressing hepatoblastoma HB611 cell treated salubrinal However increased decreased ERstress tunicamycin salubrinal treatment respectively confirmed expression analysis grp78 using Western blot addition Western blot result demonstrated expression HBV core protein large HBsAg increased decreased tunicamycin salubrinal respectively conclusion salmediated inhibition HBV replication virion production might due simultaneous reduction core large HBsAg expression maintaining ER homeostasis result HBV replication regulation modulation ERstress dynamic would useful designingidentifying antiHBV drug targeting cellular signaling pathways",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39246409/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39186570",
        "title": "Prevalence and associated risk factors of current hepatitis C infection among U.S. general population and injection drug users aged 20-59 years: NHANES 2009-2018.",
        "abstract": "people inject drug PWID attributed highrisk group transmission Hepatitis C virus HCV study assessed prevalence associated factor current HCV infection CHI among US general population PWID age 20 59 year old study utilized crosssectional data 20092018 National Health Nutrition Examination Survey conducting separate analysis US general population including PWID nonPWID well specific analysis focusing solely PWID analytical method included estimation CHI prevalence RaoScott chisquare test compare CHIpositive CHInegative groups univariate multivariable logistic regression model evaluate associated risk factor CHI prevalence CHI among general population PWID 1 19 respectively Compared nonPWID odds CHI significantly higher among PWID OR  326 95 CI  177603 general population Among PWID male vs female OR  26 95 CI  1159 adult aged 4059 vs 2039 year old OR  29 95 CI  1273 NonHispanic Black vs White OR  46 95 CI  15136 high school diploma less educational attainment vs college degree OR  35 95 CI  1492 showed higher odds CHI prevalence CHI found higher among PWID especially male aged 4059 year old NonHispanic Black lower educational attainment Targeted intervention screening awareness program among PWID population recommended reduce burden new HCV infection US",
        "mesh_terms": [
            "Humans",
            "Adult",
            "Male",
            "Female",
            "Middle Aged",
            "Risk Factors",
            "United States",
            "Prevalence",
            "Substance Abuse, Intravenous",
            "Hepatitis C",
            "Cross-Sectional Studies",
            "Nutrition Surveys",
            "Young Adult",
            "Drug Users"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39186570/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39185365",
        "title": "miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD).",
        "abstract": "bBackgroundb Early detection progressive liver damage chronic liver disease CLD patient crucial better treatment response Several study shown association microRNA miRNA progression CLD regulating cell proliferation fibrosis apoptosis well carcinogenesis bObjectivesb study aimed determining expression miRNA221 among different stage fibrosis CLD patient due hepatitis B virus HBV nonalcoholic fatty liver disease NAFLD thus evaluate role early biomarker CLD bMethodsb total 100 participant 75 CLD patient 25 healthy control recruited crosssectional study divided four groups 25 healthy control 25 CLD without fibrosis 25 CLD fibrosis 25 CLD cirrhosis Total RNA extracted plasma followed cDNA synthesis finally expression miRNA221 analyzed diagnostic potential single biomarker using qRTPCR method bResultsb plasma level miRNA221 significantly upregulated different fibrosis stage CLD ipi  005 upregulation positively correlated progression fibrosis ipi  005 Significantly increased expression miRNA221 found NAFLD patient compared HBV patient CLD without fibrosis patient group ipi  005 expression miRNA221 significantly upregulated among HBV patient CLD fibrosis group miRNA221 showed high diagnostic accuracy discriminating different stage fibrosis healthy control ipi  005 bConclusionb miRNA221 may used potential plasma biomarker early prediction fibrosis progression CLD patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39185365/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39165251",
        "title": "Microbial infection among SARS-COV-2-infected patients in a COVID-19-dedicated tertiary care hospital of Bangladesh: a cross-sectional study.",
        "abstract": "bObjectivesb study aimed determine pattern respiratory bloodborne uropathogenic microbial pathogen among SARSCoV2infected patient COVID19coronavirus disease 2019 dedicated tertiary care hospital Dhaka Bangladesh bDesignbThis crosssectional study bSettingb COVID19dedicated tertiary care hospital Dhaka Bangladesh conducted March June 2021 bParticipantsb Hospitalized individual COVID19 infection regardless age sex bPrimary secondary outcome measuresb percentage coinfected COVID19 patient characterization microorganism responsible coinfection served primary outcome measures Finding association coinfection age coinfection sex coinfection comorbidity secondary outcome variable bInterventionsb applicable bResultsbOut 79 patients 61  male mean age 4953 years Coinfection seen 77  patients 51  isolates urine samples followed 26  blood Bacteria isolated urine iEnterococcusi 26  coagulasenegative iStaphylococcusi CONS 13  iEnterobacteri spp 13  iPseudomonasi spp organism isolated blood sample Mixed growth found nasopharyngeal throat swabs predominant specie Staphylococcus aureus Streptococcus spp time data collection 557  patient given antimicrobials 304  patient given single antimicrobial HBsAg positive 13  patient none antihepatitis C dengue NS1Ag positive bConclusionb Microbial infection seen associated SARSCoV2 infection great value prescribing antimicrobial reducing fatal outcome hospitalized patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39165251/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39146948",
        "title": "WHO global research priorities for antimicrobial resistance in human health.",
        "abstract": "research agenda antimicrobial resistance AMR human health identified 40 research priority addressed year 2030 priority focus bacterial fungal pathogen crucial importance addressing AMR including drugresistant pathogen causing tuberculosis research priority encompass entire peoplecentred journey covering prevention diagnosis treatment antimicrobialresistant infections addition addressing overarching knowledge gap AMR epidemiology burden drivers policy regulations awareness education research priority identified multistage process starting comprehensive scoping review knowledge gaps expert input gathered survey open call priority setting involved rigorous modified Child Health Nutrition Research Initiative approach ensuring global representation applicability findings ultimate goal research agenda encourage research investment generation evidence better understand AMR dynamic facilitate policy translation reducing burden consequence AMR",
        "mesh_terms": [
            "Humans",
            "World Health Organization",
            "Global Health",
            "Research",
            "Drug Resistance, Bacterial",
            "Anti-Bacterial Agents",
            "Drug Resistance, Microbial",
            "Bacterial Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39146948/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39078795",
        "title": "An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines.",
        "abstract": "immunoinformatic study identified potential epitope envelopment polyprotein GnGc Rift Valley fever virus RVFV pathogenic virus causing severe fever human livestock Effective vaccination crucial controlling RVFV outbreaks identification suitable epitope crucial development safe effective vaccines Protein sequence obtained UniProt database evaluated VaxiJen v20 predict B Tcell epitope within RVFV glycoprotein GnGc protein sequence analyzed bioinformatics tool algorithms predicted Tcell Bcell epitope evaluated antigenicity allergenicity toxicity VaxiJen v20 system AllerTop v20 ToxinPred server respectively employed computational method screen RVFV envelopment polyprotein encompassing Nterminal Cterminal glycoprotein segments discover antigenic T Bcell epitopes analysis unveiled multiple potential epitope within RVFV glycoprotein specifically within GnGc protein sequences Subsequently selected eleven cytotoxic Tlymphocytes CTL four helper Tlymphocytes HTL population coverage analysis collectively extended cover 9704 worlds population representing diverse ethnicity regions Notably CTL epitope VQADLTLMF exhibited binding affinity numerous human leukocyte antigen HLA alleles identification glycoprotein GnGc epitope immunoinformatic study bear significant implication advancing development effective RVFV vaccine finding provide valuable insight immunological aspect disease may contribute towards development broadspectrum antiviral therapy targeting RNA virus similar polymerase enzymes",
        "mesh_terms": [
            "Rift Valley fever virus",
            "Epitopes, T-Lymphocyte",
            "Epitopes, B-Lymphocyte",
            "Computational Biology",
            "Humans",
            "Viral Vaccines",
            "Rift Valley Fever",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39078795/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39030061",
        "title": "Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial.",
        "abstract": "Vaccination constitutes attractive control measure hepatitis E virus HEV major cause maternal perinatal mortality globally Analysis pregnant participant effectiveness trial HEV vaccine HEV239 showed possible HEV239associated fetal losses aimed conduct detailed analysis safety signal doubleblind clusterrandomised trial 67 village Matlab Bangladesh randomly allocated 11 two vaccine groups nonpregnant woman aged 1639 year received either HEV239 HEV239 group HepaB a hepatitis B vaccine control group implemented weekly surveillance pregnancy detection followup pregnancy every 2 weeks using physicianconfirmed diagnosis evaluate fetal loss outcome miscarriage spontaneous abortion stillbirth elective termination Data parallel system reproductive health surveillance Matlab used clarify study diagnosis necessary Miscarriage assessed among participant whose first positive pregnancy test vaccination date for whichever dose closest date last menstrual period LMP 20 weeks gestation defined following analysis period interest 90 day LMP pregnancy outcome the proximal period LMP date pregnancy outcome the pregnancy period 90 day LMP LMP date 90 day preLMP period enrolment 90 day LMP the distal period Poisson Cox regression model used assess association receipt HEV239 fetal loss outcomes trial registered ClinicalTrialsgov NCT02759991 Among 19 460 nonpregnant participant enrolled trial 5011 identified pregnancy within 2 year following vaccination met criterion analysis 2407 HEV239 group 2604 control group Among participant vaccinated proximal period evaluated miscarriage miscarriage occurred 54 8·9 607 HEV239 group 32 4·5 719 control group adjusted relative risk aRR 2·0 95 CI 1·33·1 p0·0009 Similarly risk miscarriage increased HEV239 group versus control group among participant inadvertently vaccinated pregnancy 22 10·5 miscarriage among 209 participant HEV239 group v 14 5·3 266 control group aRR 2·1 95 CI 1·14·1 p0·036 among vaccinated within 90 day preLMP 32 8·0 398 v 18 4·0 453 1·9 1·13·2 p0·013 increased risk miscarriage observed received HEV239 distal period 93 5·6 1647 v 80 4·5 1773 1·3 0·81·9 p0·295 Stillbirth elective termination showed increased risk among woman administered HEV239 versus administered HepaB analysis periods HEV239 given shortly pregnancy associated elevated risk miscarriage association pose possible safety concern programmatic use HEV239 woman childbearing age Research Council Norway Innovax",
        "mesh_terms": [
            "Humans",
            "Female",
            "Bangladesh",
            "Pregnancy",
            "Adult",
            "Double-Blind Method",
            "Young Adult",
            "Viral Hepatitis Vaccines",
            "Adolescent",
            "Hepatitis E",
            "Abortion, Spontaneous",
            "Rural Population",
            "Hepatitis E virus",
            "Fetal Death"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39030061/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39030060",
        "title": "Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial.",
        "abstract": "Hepatitis E virus HEV lead high mortality pregnant woman lowincome countries aimed evaluate safety HEV vaccine effectiveness preventing hepatitis E pregnancy phase 4 doubleblind clusterrandomised trial 67 village Matlab Bangladesh randomised 11 receive HEV239 a recombinant HEV vaccine control vaccine HepaB hepatitis B vaccine using block randomisation random number table block size eight stratified cluster population size Eligible nonpregnant woman aged 1639 years vaccinated intramuscularly day 0 1 month 6 months followed 2 year last immunisation primary endpoint hepatitis E pregnant perprotocol population those received three dos within 2 day scheduled dates safety secondary endpoint assessed intentiontotreat ITT population participants received least one dose Solicited adverse event recorded first 7 day dose unsolicited event 2 year participants final dose Pregnancyrelated safety outcome assessed pregnant ITT population study registered ClinicalTrialsgov NCT02759991 Oct 2 2017 Feb 28 2019 19 460 participant enrolled received either HEV239 9478 48·7 participants 33 clusters HepaB 9982 51·3 participants 34 clusters 17 937 92·2 participant received three dos 17 613 90·5 vaccinated according protocol 8524 48·4 HEV239 group 9089 51·6 control group pregnant participant confirmed hepatitis E either treatment group HEV239 showed mild safety profile similar HepaB difference proportion solicited adverse event group severe solicited events Pain common local symptom 1215 12·8 HEV239 recipient 1218 12·2 HepaB recipients fever common systemic symptom 141 1·5 HEV239 recipient 145 1·5 HepaB recipients None serious adverse event death vaccine related Among pregnant participants HEV239 group higher risk miscarriage 136 5·7 2407 pregnant participants compared control group 102 3·9 2604 adjusted odds ratio 1·54 95 CI 1·152·08 effectiveness HEV239 pregnant woman remains uncertain HEV239 safe well tolerated nonpregnant women finding regarding miscarriage warrant investigation Research Council Norway Innovax",
        "mesh_terms": [
            "Humans",
            "Female",
            "Bangladesh",
            "Adult",
            "Double-Blind Method",
            "Hepatitis E",
            "Pregnancy",
            "Young Adult",
            "Adolescent",
            "Viral Hepatitis Vaccines",
            "Rural Population",
            "Vaccines, Synthetic",
            "Hepatitis E virus",
            "Pregnancy Complications, Infectious"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39030060/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "39016385",
        "title": "Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure.",
        "abstract": "prevalence metabolic dysfunctionassociated fatty liver disease MAFLD complication MAFLDrelated acuteonchronic liver failure MAFLDACLF rising Yet factor determining patient outcome MAFLDACLF remain understudied Patients MAFLDACLF recruited Asian Pacific Association Study LiverACLF Research Consortium AARC registry diagnosis MAFLDACLF made treating unit identified etiology chronic liver disease MAFLD or previous nomenclature nonalcoholic fatty liver disease nonalcoholic steatohepatitis nonalcoholic steatohepatitiscirrhosis Patients coexisting etiology chronic liver disease such alcohol hepatitis B virus hepatitis C virus etc excluded Data randomly split derivation n  258 validation n  111 cohort 7030 ratio primary outcome 90day mortality baseline clinical laboratory feature severity score considered derivation group 258 patients 60 male mean age 53 Diabetes noted 27 hypertension 29 dominant precipitant included viral hepatitis hepatitis virus hepatitis E virus 32 druginduced injury druginduced liver injury 29 sepsis 23 Model EndStage Liver DiseaseSodium MELDNa AARC score admission averaged 32 ± 6 104 ± 19 90 days 51 survived Nonviral precipitant diabetes bilirubin international normalized ratio encephalopathy independent factor influencing mortality Adding diabetes precipitant MELDNa AARC scores novel MAFLDMELDNa score 12 diabetes 12 nonviral precipitant MAFLDAARC score 5 each formed outperformed standard score cohorts Almost half patient MAFLDACLF die within 90 days Diabetes nonviral precipitant druginduced liver injury sepsis lead adverse outcomes new MAFLDMELDNa MAFLDAARC score provide reliable 90day mortality prediction patient MAFLDACLF",
        "mesh_terms": [
            "Humans",
            "Male",
            "Acute-On-Chronic Liver Failure",
            "Female",
            "Middle Aged",
            "Sepsis",
            "Chemical and Drug Induced Liver Injury",
            "Aged",
            "Non-alcoholic Fatty Liver Disease",
            "Diabetes Mellitus",
            "Severity of Illness Index",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39016385/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38995937",
        "title": "A qualitative study on the challenges of Afghan child labourers in Tehran.",
        "abstract": "Afghan refugee child labourer face many challenge labelled refugees attempt explore challenges present study conducted Tehran qualitative approach present qualitative research conducted using conventional content analysis approach 25 Afghan child labourer 2022 Tehran Child labourer selected purposive snowball sampling interviewed semiindepth interview data analysed based Granheim Lundmans criteria well Guba Lincoln enrich findings total 3 categories 13 subcategories 183 initial code extracted data analysis including psychological challenges history harassment abuse negative effects highrisk behaviours family detachment health challenges physical problems inappropriate accommodation medicaltherapeutic problems health threats social challenges neglected childhood dual identity educational limitations inadequate social support social isolation social humiliation individual level possible meet child labourers health need make aware hazard working street physical examination certain interval holding training workshop harassment prevention anger control prevention highrisk behaviours prevention infectious disease hepatitis strengthening selfconfidence improve health Also Afghan child labourers work could intervened social familial level providing accommodation suitable neighbourhoods providing health insurance child labourers creating chance studying schools preventing dropouts strengthening social relation order improve childrens health",
        "mesh_terms": [
            "Humans",
            "Iran",
            "Afghanistan",
            "Male",
            "Child",
            "Female",
            "Qualitative Research",
            "Refugees",
            "Child Labor",
            "Adolescent",
            "Social Support"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38995937/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38992660",
        "title": "The spectrum of health conditions in community-based cross-sectional surveys in Southeast Asia 2010-21: a scoping review.",
        "abstract": "Southeast Asia undergoing epidemiological transition noncommunicable illness becoming increasingly important yet infectious disease tuberculosis HIV hepatitis B malaria remain widely prevalent populations emerging zoonotic disease threaten also limited populationlevel estimate many important heath conditions restricts evidencebased decisionmaking disease control prevention priorities Crosssectional survey efficient epidemiological tool measure prevalence wide range diseases systematic assessment coverage different health condition produced region conducted systematic search Medline Embase Global Health CINAHL Scopus Web Science Core Collection Global Index Medicus additionally Google Scholar inclusion criterion crosssectional survey conducted communitybased recruitment Bangladesh Cambodia Laos Myanmar Thailand published January 1 2010 January 27 2021 reporting prevalence health condition 542 publication 337 survey included Noncommunicable condition n  205 reported survey infectious condition n  124 Disability n  49 selfreport history disease symptom n  35 selfperceived health status n  34 reflect holistic picture health studied many fewer surveys addition 45 survey studied symptomatic condition overlap noncommunicable infectious conditions surveyed condition undernutrition obesity hypertension diabetes intestinal parasites malaria anemia diarrhea fever acute respiratory infections condition overlap important cause death disability Global Burden Disease study However highburden condition eg hearing loss headache disorder low back pain chronic liver kidney diseases cancers rarely studied relatively recent survey estimate representative prevalence trend health condition beyond known high burden Expanding spectrum health condition crosssectional survey could improve understanding evolving disease pattern region",
        "mesh_terms": [
            "Humans",
            "Asia, Southeastern",
            "Communicable Diseases",
            "Cross-Sectional Studies",
            "Health Status",
            "Health Surveys",
            "Noncommunicable Diseases",
            "Prevalence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38992660/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38944709",
        "title": "Comparative Study of Treatment Outcome with Tenofovir Alafenamide and Entecavir in Patients with HBV Related Acute on Chronic Liver Failure.",
        "abstract": "Major cause acute insult Hepatitis B virus related acute chronic liver failure Asian region reactivation Hepatitis B virus super infection hepatitis E virus ACLF Anti viral therapy started soon possible ACLF patient presentation waiting confirmation HBV DNA level randomized controlled trial carried Department Hepatology BSMMU Bangladesh September 2019 august 2020 Hepatitis B virus related ACLF patient trial conducted among twenty seven HBV acute chronic liver failure patient compare Child Turcotte pugh CTP score Model end stage liver disease MELD score Asia Pacific Association study Liver APASL ACLF Research consortium AARC score survival patient HBV DNA level 3 month antiviral therapy tenofovir alafenamide 25mg entecavir 05mg group CTP score MELD score AARC score significantly p005 decline baseline subsequent followup 1st at 7 days 2nd at 14 days 3rd at 30 days 4th at 90 days group non significant p005 difference occurred two group twenty seven patient detectable HBV DNA level pretreatment survived patient became undectable 4th 90 day followup Total 10 patient 3707 survived 90 day followup seven patient 700 tenofovir alafenamide group three patient 300 entecavir group statistically significant p005 two group Hepatic encephalopathy hepatorenal syndrome common cause death groups drug tenofovir alafenamide entecavir significantly improves liver function former one superior regarding survival",
        "mesh_terms": [
            "Humans",
            "Tenofovir",
            "Guanine",
            "Antiviral Agents",
            "Male",
            "Acute-On-Chronic Liver Failure",
            "Female",
            "Adult",
            "Middle Aged",
            "Treatment Outcome",
            "Alanine",
            "Hepatitis B",
            "Hepatitis B virus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38944709/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38808441",
        "title": "Recent Insights into the Antimicrobial Properties of Phyllanthus emblica L.: A Comprehensive Review of Wonder Berry.",
        "abstract": "Phyllanthus emblica L Amla known therapeutic property used medicinal plant rich vitamin C bioactive phytochemical like polyphenols gallic acid chebulagic acid leutolin quercetin etc Different part plant used treat various viral bacterial fungal diseases review article summarizes recent literature relevant antiviral antibacterial antifungal effect P emblica variety bacteria Staphylococcus aureus Bacillus subtillus Enterococcus faecalis Salmonella typhi Escherichia etc fungi Alternaria alternate Botroyodiplodia theobromae Colletotrichum corcori Curvularia lunata Fusarium exquisite Fusarium solanii Aspergillus niger Candida albicans Colletotrichum gleosparoitis Macrophomina phaseolina viruses like Influenza virus strain H3N2 hepatitis B Human Immunodeficiency virus type1 HIV1 Simplex virus type 1 HSV1 type 2 HSV2 experimented Different technique used based way identification For example disc diffusion dilution methods sound diffusion Immunoperoxidase monolayer assay serum HBV HBsAg assay enzyme immunoassay etc present review analyzed summarized antimicrobial activity P emblica possible mechanism action provide future direction translating finding clinically",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Anti-Infective Agents",
            "Antifungal Agents",
            "Antiviral Agents",
            "Bacteria",
            "Fruit",
            "Fungi",
            "Microbial Sensitivity Tests",
            "Phyllanthus emblica",
            "Plant Extracts",
            "Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38808441/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38724531",
        "title": "Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.",
        "abstract": "Sputum culture reversion conversion indicator tuberculosis TB treatment failure analyze data endTB multicountry prospective observational cohort NCT03259269 estimate frequency primary endpoint among individual receiving longer 18to20 month regimen multidrug rifampicinresistant MDRRR TB experienced culture conversion also conduct Cox proportional hazard regression analysis identify factor associated reversion including comorbidities previous treatment cavitary disease conversion low body mass index BMI conversion time conversion number likelyeffective drugs 1286 patients 54 42 experienced reversion median 173 day 97306 conversion Cavitary disease BMI  185 hepatitis C prior treatment secondline drugs longer time initial culture conversion positively associated reversion Reversion uncommon cavitary disease low BMI hepatitis C prior treatment secondline drugs culture conversion delayed may benefit close monitoring following conversion",
        "mesh_terms": [
            "Humans",
            "Antitubercular Agents",
            "Sputum",
            "Tuberculosis, Multidrug-Resistant",
            "Diarylquinolines",
            "Male",
            "Female",
            "Oxazoles",
            "Adult",
            "Nitroimidazoles",
            "Middle Aged",
            "Prospective Studies",
            "Mycobacterium tuberculosis",
            "Drug Repositioning"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38724531/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38679925",
        "title": "Crowdsourcing to increase hepatitis B and C testing and reduce hepatitis stigma among medical students in Bangladesh.",
        "abstract": "study address pervasive challenge low hepatitis B HBV hepatitis C HCV testing rate coupled stigma associated disease low middleincome country LMICs special focus Bangladesh study aim introduce innovative crowdsourcing intervention involves medical students crucial cohort potential shape healthcare attitudes structured crowdsourcing approach study design implement digital intervention counter stigma promote testing among medical student Dhaka Bangladesh Participants submitted brief video text aiming encourage hepatitis testing reduce stigma call advertised meetings emails social media welcomed entry English Bengali 3 weeks panel six judge evaluated entry based clarity impact potential innovation feasibility sustainability awarding prize student behind highestrated submissions Seventeen video four text message received average score 55 among 440 surveyed medical students predominantly 22 year old 16 fourth year 21 viewing 360 student underwent screening identifying two previously undiagnosed HBV case referred care HCV infection found Notably 41 expressed concern individual HBV working hospital doctor living HBV conclusion pilot showcase power medical student spearheading campaign counter hepatitis stigma encourage testing utilizing crowdsourcing study introduces innovative approach persistent issue LMICs specially Bangladesh offering model could potentially adapted region grappling similar challenges",
        "mesh_terms": [
            "Humans",
            "Students, Medical",
            "Bangladesh",
            "Social Stigma",
            "Hepatitis C",
            "Hepatitis B",
            "Male",
            "Female",
            "Crowdsourcing",
            "Young Adult",
            "Adult",
            "Mass Screening"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38679925/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38648414",
        "title": "Clinical and laboratory profile of Expanded Dengue Syndrome: experience of 2019 outbreak from Dhaka, Bangladesh.",
        "abstract": "Bangladesh afflicted periodic dengue outbreak every year one worst upsurge recorded 2019 increasing trend dengue unusual symptom common before study aim describe experience three tertiary care centre Dhaka regarding clinical laboratory hospital outcome management profile Expanded Dengue Syndrome EDS case admitted 2019 outbreak current work crosssectional observational study took place August 1 December 31 2019 three major tertiary care centre Dhaka Bangladesh total 2017 screened dengue cases 49 met inclusion criterion 39 enrolled taking informed written consent Data analysed using Microsoft Excel Graph pad prism 931 probability value p005 considered statistically significant 39 cases majority male 7949 median ±IQR age 33±9 years Hypertension 4 1026 commonly associated comorbidity Among systemic manifestations prevalent hepatitis 3849 followed encephalopathy 1282 Majority patient suffering primary infection 85 Case fatality rate 1538 Hepatitis meningoencephalitis predominant cause death study record known case report Acute respiratory dress syndrome ARDS complicating dengue Bangladesh None patient cohort managed steroids two 513 39 case received antibiotics year 2019 unusual rise EDS case 154 fatality observed study Hepatitis common presentation cause death Here report first ARDS case encountered Bangladesh Despite multifaceted presentation EDS indiscriminate use antibiotic steroid minimal Early recognition multifarious feature EDS important choosing targeted treatment option avert many deaths result study underline necessity indepth research risk factor contributing mortality EDS cases",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Male",
            "Female",
            "Adult",
            "Cross-Sectional Studies",
            "Dengue",
            "Disease Outbreaks",
            "Young Adult",
            "Tertiary Care Centers",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38648414/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38624203",
        "title": "Complete genome sequence of hepatitis B virus identified from a patient suffering from chronic kidney disease in Bangladesh.",
        "abstract": "Hepatitis B virus HBV infection reported risk factor chronic kidney disease CKD study sequenced complete genome HBV strain identified CKD patient Bangladesh followed genomic characterization mutational analyses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38624203/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38515143",
        "title": "Assessment of preventive practices towards hepatitis B infection among nursing students in Bangladesh: role of knowledge, attitudes and sociodemographic factors.",
        "abstract": "Globally hepatitis B infection HBI pose substantial public health concern healthcare workers including nursing students higher risk contracting disease Thus study aimed assess knowledge attitudes sociodemographic factor associated HBI prevention among sample Bangladeshi nursing students crosssectional survey performed among 737 nursing student nursing institute Khulna Barishal division Bangladesh January April 2023 data collected providing questionnaire structured questionnaire classroom following stratified random sampling process model multinomial logistic regression used evaluate factor linked HBI prevention practices mean SD score 1142 ± 288 knowledge 433 ± 191 attitude 427 ± 2056 practice respectively Participants low knowledge adjusted odds ratio aOR  2562 95 CI 129507 poor attitude aOR  5730 95 CI 3191028 regarding HBI significantly associated higher likelihood poor practice towards HBI prevention Moreover 2nd year nursing student aOR  2147 95 CI 119386 aged 1920 year aOR  3038 95 CI 130709 married aOR  0320 95CI 013082 family history HBI aOR  0134 95CI 005036 significantly associated poor practice HBI prevention among study participants knowledge attitude practice score nursing student HBI prevention suboptimal advocate implementing regular HBI prevention education policies free subsidized services skill development proper HBI prevention enforcement strict professional ethic within nursing colleges effort predominantly focus secondyear aged 1920 unmarried nursing students",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38515143/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38497497",
        "title": "Annual risk of hepatitis E virus infection and seroreversion: Insights from a serological cohort in Sitakunda, Bangladesh.",
        "abstract": "Hepatitis E virus HEV major cause acute jaundice South Asia Gaps understanding transmission driven nonspecific symptom scarcity diagnostics impeding rational control strategies context serological data provide important proxy measure infection enrolled populationrepresentative serological cohort 2337 individual Sitakunda Bangladesh estimated annual risk HEV infection seroreversion using serostatus change paired serum sample collected 9 month apart fitting catalytic model agestratified crosssectional seroprevalence baseline 15 95 CI 1417 people seropositive seroprevalence highest relatively urban south study 27 individual seroreverted annual seroreversion risk 15 95 CI 1021 38 seroconverted annual infection risk 3 95CI 25 Relying crosssectional seroprevalence data alone ignoring seroreversion underestimated annual infection risk fivefold 06 95 CrI 0506 accounted observed seroreversion reversible catalytic model infection risk consistent measured seroincidence result quantify HEV infection risk Sitakunda highlight importance accounting seroreversion estimating infection incidence crosssectional seroprevalence data",
        "mesh_terms": [
            "Humans",
            "Hepatitis E virus",
            "Bangladesh",
            "Seroepidemiologic Studies",
            "Cross-Sectional Studies",
            "Hepatitis E",
            "Hepatitis Antibodies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38497497/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38460060",
        "title": "Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections.",
        "abstract": "Endstage liver disease ESLD lifethreatening clinical syndrome complicated infection mortality markedly increased patient ESLD bacterial fungal infection induce aggravate occurrence progression liver decompensation Consequently infection among common complication disease deterioration overwhelming need standardized protocol early diagnosis appropriate management patient ESLD complicated infections Asia Pacific region largest number ESLD patients due hepatitis B growing population alcohol NAFLD Concomitant infection add organ failure high mortality also financial healthcare burdens consensus document assembled uptodate knowledge experience colleague across AsiaPacific region providing data principle well evidencebased current working protocol practice diagnosis treatment patient ESLD complicated infections",
        "mesh_terms": [
            "Humans",
            "Bacterial Infections",
            "Consensus",
            "End Stage Liver Disease",
            "Mycoses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38460060/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38367678",
        "title": "Comprehensive analysis of antigenic variations and genomic properties of hepatitis B virus in clinical samples in the mid-north east region of Bangladesh.",
        "abstract": "investigation delineates exhaustive analysis clinical immunological genomic landscape hepatitis B virus HBV infection across cohort 22 verified patients demographic analysis unveiled pronounced male bias 7727 patient age spanning 20 85 year duration illness ranging 10 day 4 years Predominant clinical manifestation included fever fatigue anorexia abdominal discomfort arthralgia alongside observed comorbidities chronic renal disorder hepatocellular carcinoma Antigenic profiling HBV envelope protein elucidated significant heterogeneity among infected subjects particularly highlighted discordance detection capability small large HBsAg assays suggesting antigenic diversity Quantitative assessment viral load unveiled broad spectrum accompanied atypical HBeAg reactivity patterns challenging reliability existing serological markers Correlative study viral burden antigenicity envelope protein unearthed phenomenon indicative diagnostic evasion Notably sample demonstrating robust viral replication paradoxically undetectable large HBsAg ELISA kit advocating sophisticated diagnostic methodologies Genotypic examination three HBV isolates classified genotype D2 phylogenetic alignment strain various global origins Mutational profiling identified pivotal mutation within basic core promoter preS2S1 regions associated augmented risk hepatocellular carcinoma Further mutation discerned small HBsAg RToverlap region recognized contributor vaccine andor diagnostic escape mechanisms summation scholarly discourse elucidates intricate interplay clinical presentations antigenic diversity genomic attribute HBV infection accentuating imperative ongoing investigative endeavor refine diagnostic therapeutic modalities",
        "mesh_terms": [
            "Humans",
            "Male",
            "Hepatitis B virus",
            "Hepatitis B Surface Antigens",
            "Carcinoma, Hepatocellular",
            "Bangladesh",
            "Phylogeny",
            "Reproducibility of Results",
            "Hepatitis B",
            "Mutation",
            "Genotype",
            "Liver Neoplasms",
            "Antigenic Variation",
            "Genomics",
            "DNA, Viral",
            "Hepatitis B, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38367678/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38367629",
        "title": "Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.",
        "abstract": "top 20 highest burdened country in disabilityadjusted life years account 75 global burden viral hepatitis effective response 20 country crucial global elimination target achieved update Lancet Gastroenterology  Hepatology Commission accelerating elimination viral hepatitis convene national expert top 20 highest burdened country provide update progress Although global burden disease falling progress towards elimination varies greatly country use hepatitis elimination policy index conceived part 2019 Commission measure countries progress towards elimination Progress elimination policy made 14 20 country highest burden since 2018 substantial gain observed Bangladesh India Indonesia Japan Russia improvement attributable publication formalised national action plan elimination viral hepatitis provision publicly funded screening programmes government subsidisation antiviral treatments Key theme emerged discussion national commissioner highest burdened country build original recommendation accelerate global elimination viral hepatitis theme include need simplified model care improved access appropriate diagnostics financing initiatives rapid implementation lesson COVID19 pandemic",
        "mesh_terms": [
            "Humans",
            "Gastroenterology",
            "Pandemics",
            "Hepatitis",
            "Hepatitis A",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38367629/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38361592",
        "title": "Monitoring and evaluation practices and operational research during public health emergencies in southeast Asia region (2012-2022) - a systematic review.",
        "abstract": "systematic review aimed explore monitoring evaluation ME operational research OR practice public health emergency PHE southeast Asian region SEAR last decade searched electronic database grey literature source study published 2012 2022 study written English included narrative synthesis undertaken total 29 study included review Among 25 study documented ME four study documented practices majority study India Bangladesh evidence found Sri Lanka Bhutan Myanmar TimorLeste ME surveillance program identified among PHE due COVID19 prevalent ME conducted response COVID19 cholera Nipah Ebola iCandida aurisi hepatitis A practice minimal reported India Indonesia India conducted COVID19 malaria whereas Indonesia focused COVID19 influenza SEAR country mechanism conducting ME noticeable limitation practices compelling need develop standard framework ME Additionally enhancing private sector engagement crucial strengthening preparedness PHE Furthermore necessity increase awareness importance conducting ME PHE",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38361592/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38344624",
        "title": "A Systematic Review of Pediatric Dialysis in Asia: Unveiling Demographic Trends, Clinical Representation, and Outcomes.",
        "abstract": "Dialysis pediatric group complicated wide range factor affect longterm prognosis purpose metaanalysis systematic review better understand demographic clinical factor affect dialysis success children searched variety database relevant article included 14 report dealt case study pediatric patient undergoing dialysis wide range renal diseases Patients demographics clinical presentations laboratory findings treatment outcome primary area data collection get better sense overall prevalence certain outcome spot noteworthy trend pattern disease process conducted metaanalysis Variations dialysis efficacy outcome highlighted throughout wide range age pediatric dialysis cohort neonate teenagers Acute kidney injury AKI tended impact boys chronic kidney disease CKD lupus nephritis disproportionately afflicted girls Many different ethnic group represented evidence disease hereditary component common area others However potential longterm consequence remained concern Hemodialysis found effective controlling endstage renal disease ESRD AKI patient going kidney transplant time peritoneal dialysis associated increased risk infection comprehensive analysis highlight importance demographic clinical parameter determining pediatric dialysis outcomes 1447 mortality rate gender disparity revealed metaanalysis pediatric renal diseases included cohort 235 patient condition like lupus nephritis hepatitis C infection finding stress necessity individualized treatment technique suggest demographic characteristic addressed prognostic models better patient outcomes study also suggests standardized reporting pediatric dialysis studies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38344624/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38236834",
        "title": "Social and structural determinants associated with the prevalence of sexually transmitted infections among female commercial sex workers in Dhaka City, Bangladesh.",
        "abstract": "Female commercial sex worker FCSWs bear higher rate sexually transmitted infection STIs among key populations association structural determinant STIs among FCSWs forefront research earlier Bangladesh study examined structural factor correlate prevalence STIs physicalsocialeconomicpolicy level among FCSWs Dhaka city 495 FCSWs screened HIV hepatitis B syphilis Structural variable Individual risks highrisk sexual behaviors work environments extracted previous multilevel study FCSWs analyzed 2020 determine whether macromicrostructural factor associated STIs prevalence STIs 436 95 CI 39148 n  207495 FCSWs infected Syphilis Hepatitis B 18 coinfection none positive HIV Multiple logistic regression revealed Individual risk factor like age ≤18 years adjusted odds ratio  AOR  28 181299 years AOR  57 year sex industry 1 year AOR  15 15 years AOR  39 condom contraceptive AOR  27 significantly associated STIs Considering Highrisk behaviors like monthly coitus regular client AOR  33 performing anal sex ever AOR  03 consistent condom use AOR  13 less likely associated STIs P005 association ever group sex STIs reported double AOR  21 Work environment like sex roadsparksshrinesmarkets AOR  26 ever HIVtesting AOR  25 significantly linked STIs However microlevel factor like experiencing forced sex past year AOR  179 condom collected hotel boy AOR  34 significantly associated STIs Hierarchical model increasing modelpower Microstructural determinant predominated Macropolicylevel factors profoundly influenced STIs FCSWs need comprehensive integrated intervention promote accurate condom use perception eliminate risky sexual behaviors provide quality reproductive health care Necessary step policy level urgently needed decriminalize commercial sex work",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38236834/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38223570",
        "title": "Prevalence of hepatitis B and C, and syphilis among aspirant migrant workers of Bangladesh.",
        "abstract": "Bangladesh labour migration source employment workers remittance critical poverty mitigation aim study assess prevalence hepatitis B C HIV tuberculosis syphilis kidney liver disease along presence infection among aspirant migrant worker Bangladesh study carried SeptemberDecember 2019 analysed data collected screening test specific disease aspirant workers test prevalence computed 95 confidence interval Association categorical data determined Chisquare test total 2385 aspirants 1988 8335 males aged 18 65 year 2976±6578 studied Positive result screening test HBsAg 38 16 antiHCV 2 008 TPHA 25 105 VDRL 5 021 though individual positive HIV TB Elevated level SGOT n99 42 SGPT n322 135 RBS n57 24 bilirubin n46 192 creatinine n7 03 ESR n19 08 found workers Diagnosis disease worker obligatory going abroad safeguard health worker resident destination country Consequently contribute reducing global burden infectious diseases",
        "mesh_terms": [
            "Male",
            "Humans",
            "Adolescent",
            "Young Adult",
            "Adult",
            "Middle Aged",
            "Aged",
            "Female",
            "Syphilis",
            "HIV Infections",
            "Transients and Migrants",
            "Prevalence",
            "Bangladesh",
            "Hepatitis B",
            "Hepatitis B Surface Antigens"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38223570/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38222956",
        "title": "A Narrative Review on the Specific Pattern of HBV Genotype in Bangladesh: Clinical Implications for Management.",
        "abstract": "Bangladeshs unique epidemiological landscape present intriguing puzzle South Asian nation complex sociodemographic environmental factors home diverse array hepatitisB virus HBV genotypes identified Genotype C Genotypes also making significant contribution viral landscape Reviewing insight necessary underscore countrys regional diversity HBV strain also bring focus clinical implication genetic variation may disease progression management thorough database search covered various source using relevant keywords like Hepatitis B virus genotypes HBV genotype Bangladesh HBV clinical implications review synthesized finding analyzed HBV genotype prevalence clinical implication Bangladesh Genotypes C collectively represent 82 chronic hepatitisB infection CHB case Bangladesh underscoring regional prevalence geographic context pivotal understanding HBV infection dynamic disease progression area Notably genotype C presence A1762TG1764A mutation appear distinct impact disease development potentially affecting immune response CHB patients highlight need tailored management approach specific region research vital confirm elaborate findings particularly relation mutation influence hosts immune response summary study HBV genotype Bangladesh stress need genotypespecific clinical consideration research improve diagnostics therapies Raihan R Akbar SMF Narrative Review Specific Pattern HBV Genotype Bangladesh Clinical Implications Management Euroasian J HepatoGastroenterol 2023132152158",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38222956/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38222954",
        "title": "Depression among Patients with Chronic Hepatitis B: A Cross-sectional Study in a Tertiary Hospital of Bangladesh.",
        "abstract": "Patients chronic hepatitis B suffer physical illness Rather often present mental health consequence chronic disease major objective assess level depression among patient chronic hepatitis B Department Hepatology Bangabandhu Sheikh Mujib Medical University directed study comparative crosssectional study time duration September 2021 September 2022 Incidence grading depression patient chronic hepatitis B HBsAg negative healthy volunteer assessed compared study association different variable depression among chronic hepatitis B CHB patient also measured 90 patient chronic hepatitis B 52 578 found degree depression whereas among 90 HBsAgnegative healthy controls 32 356 found various degree depression dissimilarity two group significantly determined ipivalue  005 majority depressed population group mild degree depression however variance top notch ipivalue  005 prevalence moderate depression moderately severe depression statistically significant among CHB patient compared counterpart controls Depression among CHB patient found femalepredominant study shown higher prevalence depression among patient chronic hepatitis B compared HBsAgnegative healthy controls Rahman M NoorEAlam SM Rahim MA iet ali Depression among Patients Chronic Hepatitis B Crosssectional Study Tertiary Hospital Bangladesh Euroasian J HepatoGastroenterol 20231327983",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38222954/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38222949",
        "title": "Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac.",
        "abstract": "HeberNasvac recently developed therapeutic vaccine chronic hepatitis B CHB administered intranasal IN subcutaneous SC route 14 days10 dos schedule compare different schedule route immunizations group patient received four different vaccination regimen placebocontrolled factorial study Subsequently patient followed minimum time 48 weeks Samples collected end followup compared initial samples Groups II received product INSC routes every 14 7 days respectively Groups III IV treated SC route alone following 14 7 day schedule group 21 CHB patient received vaccine four different schedule eight patient received placebo total 29 patient enrolled 619 vaccinee reduced VL ≥2Log compared baseline level 25 placebo group 476 vaccine reduced HBV level undetectable 25 placebo HBeAg loss seroconversion antiHBeAg achieved vaccinees 4 9 444 40 8 20 developed antiHBs response none placebo group Reduction HBsAg level ≥1Log achieved 350 vaccinee none placebotreated patients Considering individual factorial analysis significant HBV DNA reduction detected group II immunized INSC routes significantly higher proportion patient reducing VL ≥2Log also detected grouping patient treated INSC route G  II grouping inoculated every 14 day G  III 727 636 respectively compared placebo group 250 patient immunized every 14 day G  G III also reduced HBsAg level compared baseline conclusion 48 week treatmentfree followup HeberNasvactreated patient demonstrated superior response compared placebo group term antiviral serological responses factorial analysis evidenced schedule combining route immunization frequency 14 day resulted stronger antiviral serological responses Present result support study INonly immunization schedule future consistent previous results Longlasting followup done explore histological variable progression serological variable order detect late responders Freyre FM Aguiar JA Cinza Z iet ali Impact Route Schedule Immunization Serological Virological Response Chronic Hepatitis B Patients Treated HeberNasvac Euroasian J HepatoGastroenterol 20231327378",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38222949/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38179453",
        "title": "TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview.",
        "abstract": "Tollike receptor TLR agonists potent adjuvants gained attention vaccine research ability enhance immune responses study focus application improving vaccine efficacy key viral infections including hepatitis B virus HBV hepatitis C virus HCV human immunodeficiency virus HIV SARSCoV2 influenza virus flaviviruses including West Nile virus dengue virus chikungunya virus Vaccines crucial preventing microbial infections including viruses adjuvant play vital role modulating immune responses However still many disease effective vaccine lacking limited immune response posing significant threat human health use TLR agonist adjuvant viral vaccine formulation hold promise improving vaccine effectiveness tailoring adjuvant specific pathogens HBV HCV HIV SARSCoV2 influenza virus flavivirus protective immunity chronic emerging infectious disease elicited",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38179453/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38081982",
        "title": "Effects of neddylation on viral infection: an overview.",
        "abstract": "Neddylation posttranslational modification play important role cancer development also regulating viral infection replication Upregulation neddylation occurs viral infections inhibition neddylation suppress viral replication Neddylation thought enhance viral protein stability replication Neddylation reported enhance stability regulatory hepatitis B virus HBV X protein modulate viral replication enhance hepatocarcinogenesis Inhibition neddylation using NEDD8activating enzyme E1 inhibitor MLN4924 inhibits viral replication including HBV Understanding role neddylation viral infection critical developing new therapeutic target potential treatment strategies review discus recent progress understanding effect neddylation viral infection particularly HBV infection strategy curing viral infection targeting neddylation pathway",
        "mesh_terms": [
            "Humans",
            "NEDD8 Protein",
            "Ubiquitins",
            "Neoplasms",
            "Protein Processing, Post-Translational",
            "Virus Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38081982/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38064471",
        "title": "HBV prevalence in Sub-continental countries: A systematic review and meta-analysis.",
        "abstract": "Hepatitis B virus HBV major source disease burden worldwide estimated 296 million individual living infection worldwide Although vaccine program exist control infections certain subpopulations around world continue high prevalence HBV infection systematic search study HBV published 2010 conducted India Pakistan Bangladesh Nepal Sri Lanka Bhutan paper independently screened risk bias inclusion Data extracted included study analysed estimate pooled prevalence conduct subgroup analyses Randomeffects model used estimating summary prevalence due high level heterogeneity studies funnel plot combined Eggers test assess publication bias Metaregression conducted investigate source betweenstudy heterogeneity pooled prevalence HBV across study 3 95 CI 002 005 country multiple studies pooled prevalence India 3 95 CI 002 004 Pakistan 6 95 CI 003 009 Bangladesh 5 95 CI 002 012 Nepal 1 95 CI 000 008 evidence publication bias high level heterogeneity across studies Risk bias analysis found study fair moderate quality prevalence HBV among country subcontinent higher global average high regions Countries greater number displaced person higher prevalence HBV wide range prevalence subpopulation likely reflecting differential uptake implementation vaccination programs",
        "mesh_terms": [
            "Humans",
            "Hepatitis B virus",
            "Prevalence",
            "Hepatitis B",
            "India",
            "Pakistan"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38064471/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38031080",
        "title": "The burden of HEV-related acute liver failure in Bangladesh, China and India: a systematic review and meta-analysis.",
        "abstract": "Hepatitis E potentially progress HEVrelated acute liver failure HEVALF East South Asia bear substantial burden HEV infection Bangladesh China India facing severe threat region Therefore conducted systematic review metaanalysis evaluate burden HEVALF three highrisk countries systematic literature search performed utilizing PubMed Cochrane Library Medline Embase Web Science databases Studies English Chinese reported data burden HEVALF Bangladesh China India included Outcomes pooled metaanalysis utilizing R software Estimates calculated randomeffects models subgroup analysis sensitivity analysis conducted address heterogeneity Eggers test Beggs test performed assess publication bias total 20 eligible study included study pooled HEVattributable proportion viralrelated acute liver failure estimated 400 95 CI 028052 300 95 CI 018044 610 95 CI 049072 among nonpregnant individual India China Bangladesh Indian pregnant females 710 95 CI 062079 combined prevalence among nonpregnant HEVinfected participant 280 95 CI 020037 100 95 CI 001028 India China 340 95 CI 027042 Indian pregnant female HEV infection overall mortality HEVALF estimated 320 95 CI 023042 640 95 CI 050077 among nonpregnant pregnant participant India 230 95 CI 014034 Chinese nonpregnant participants burden HEVALF Bangladesh China India nonnegligible despite geographic population heterogeneity prevention HEV infection early recognition HEVALF great significance especially highrisk country populations PROSPERO registration ID CRD42022382101",
        "mesh_terms": [
            "Pregnancy",
            "Female",
            "Humans",
            "Bangladesh",
            "Hepatitis E virus",
            "Liver Failure, Acute",
            "India",
            "China"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38031080/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "38027884",
        "title": "Seroprevalence of hepatitis E virus (HEV) among male craft and manual workers in Qatar (2020-2021).",
        "abstract": "rapid growth Qatar last two decade attracted large influx immigrant craft manual worker CMWs seeking employment job associated food handling domestic service construction Nearly 60  Qatars population expatriate CMWs including many hyperendemic country HEV Thus estimating seroprevalence HEV Qatar understanding epidemiology essential public health effort control HEV transmission Qatar Blood sample 2670 CMWs collected 2020 2021 sample tested HEVIgG antibodies Positive HEVIgG sample tested HEVIgM antibodies positive also tested viral antigen using HEVAg ELISA kit HEVRNA RTPCR confirm current HEV infections seroprevalence HEVIgG 273  7292670 95  CI 256290 HEVIgG positive 823  60729 95  CI 630105 HEVIgM positive IgMpositive samples 2 HEVRNA positive 339  95  CI 040117 1 HEVAg positive 169  95  CI 004909 addition HEVIgG seroprevalence associated age nationality highest seroprevalence participant Egypt IgG 600  IgM 556  Pakistan IgG 590  IgM 224  Nepal IgG 293  IgM 270  Bangladesh IgG 278  IgM 245  India IgG 239  IgM 243  study showed seroprevalence HEV among CMWs slightly higher previously reported among urban population Qatar 20132016",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38027884/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37974105",
        "title": "Public healthcare system utilization for chronic hepatitis C infection in Vietnam.",
        "abstract": "Healthcare utilization typically adversely affected treatment expensive requires multiple visits examined determinant healthcareseeking Hepatitis C virus HCV infection asymptomatic chronic requires costly treatment urban tertiary care referral hospital Vietnam conducted secondary analysis hospital data patient attending Hospital Tropical Diseases Ho Chi Minh City Vietnam 2017 2020 specifically HCV infection treatment Poisson regression used determine effect personal factor age sex comorbidities structural factor health insurance proximity facility seasonality year visit number hospital visits 2017 2020 total 22052 eligible patient sought treatment hospital Among patients 504 male 587  50 year age mean number visit per person 217 multivariate analysis compared 2017 number hospital visit increased 4 2018 significantly decreased 2019 2020 Visit number significantly lower 6 among South East region resident compared Central Highlands lived away hospital visit number significantly higher among older age group 511 health insurance 6 comorbidities 5 compared others Although number hospital visit female higher 7 male 2017 significantly decreased subsequent years study indicated structural individual factor affecting number visit HCV treatment meet global strategy elimination HCV Vietnam Government need address structural personal barrier healthcare seeking special focus women",
        "mesh_terms": [
            "Male",
            "Humans",
            "Female",
            "Aged",
            "Hepatitis C, Chronic",
            "Vietnam",
            "Hepatitis C",
            "Hepacivirus",
            "Patient Acceptance of Health Care"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37974105/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37973326",
        "title": "People who inject drugs: testing and treatment of HIV and HCV.",
        "abstract": "",
        "mesh_terms": [
            "Humans",
            "Drug Users",
            "HIV Infections",
            "Substance Abuse, Intravenous",
            "Hepatitis C",
            "Hepacivirus"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37973326/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37915649",
        "title": "Hepatitis is still a major health concern in Pakistan: short communication.",
        "abstract": "Hepatitis often called silent killer patient remain asymptomatic hence remain unaware illness either diagnosed incidentally get symptomatic illness advance year getting infection Pakistan transmission increased due ignorance sterilization techniques sharing personal items unsafe healthcare practice burden liver cancer transplant risen threefold past 20 years Chronic hepatitis often go undetected leading rise liver cancer transplants Pakistan bear secondlargest burden hepatitis C globally nationwide prevalence 48 2015 2019 5 increase hepatitis Crelated death 8 increase hepatitis Brelated deaths last 4 years 110 million population 281 578 individual screened hepatitis B C 1 634 614 individual registered various hepatitis clinics However 278 308 patient treated Despite national vaccination strategy coverage fall short regular screening neglected burden hepatitisrelated morbidity considerable challenge Pakistani government healthcare system lowincome country limited health resource limited access treatment Increased awareness education emphasizing preventive measures hepatitis B vaccination crucial Careful supervision healthcare worker promotion safe practice essential Pakistan learn implement Egypt model combat hepatitis effectively article aim discus barrier challenge provides possible recommendations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37915649/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37872525",
        "title": "The impact of COVID-19 on hepatitis B and C virus prevention, diagnosis, and treatment in Bangladesh compared with Japan and the global perspective.",
        "abstract": "study aimed assess effect COVID19 hepatitisrelated service Bangladesh compared situation study conducted Japan globally conducted online crosssectional questionnaire survey among clinician four society associated liver disease Bangladesh October December 2022 questionnaire included question survey conducted Japan globally total 83 clinician 8 division Bangladesh participated 663 head departmentsinstitutions Except HCV treatment initiation 30 clinician reported 7699 decline services Compared Japan global survey significantly higher decline HBV HCV service Bangladesh resume service back preCOVID19 levels Patient anxiety fear Bangladesh Survey 807 v Japan Survey 674 v Global Survey 379 p  00001 loss space due COVID19 Bangladesh Survey 639 v Japan Survey 347 v Global Survey 194 p  00001 main challenges part mitigation strategy usage telemedicine Bangladesh Survey 831 vs Japan Survey 673 v Global Survey 786 p  00001 COVID19 benefits increased laboratory testing platform Bangladesh Survey 771 v Japan Survey 179 v Global Survey 418 p  00001 reported significantly higher Bangladesh Japan global survey servicesrelated HBV HCV highly affected greatest impact month COVID19 Bangladesh decline level higher Japan global survey Repeated countermeasure COVID19 constrained healthcaresystem probable reason Bangladesh Positive impact resulting COVID19 countermeasure utilized national hepatitis program Bangladesh",
        "mesh_terms": [
            "Humans",
            "Japan",
            "Bangladesh",
            "Cross-Sectional Studies",
            "COVID-19",
            "Hepatitis B",
            "Hepatitis C",
            "COVID-19 Testing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37872525/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37868514",
        "title": "A Case of Disseminated Histoplasmosis Presenting As Adrenal Insufficiency With Granulomatous Hepatitis.",
        "abstract": "Histoplasmosis fungal infection caused iHistoplasma capsulatumi United States histoplasmosis endemic Mississippi River Valley Ohio Histoplasmosis often asymptomatic immunocompetent individuals severe disseminated case often seen immunosuppressed patients Disseminated histoplasmosis often affect reticuloendothelial system invading specific visceral organ liver spleen pancreas current study present unique case disseminated histoplasmosis 64yearold immunocompetent male patients presentation included 40lb weight loss year bilateral adrenal nodules abnormal liver enzymes granulomatous hepatitis initially raised suspicion malignant etiology adrenal mass biopsy showed fungal morphology confirmed iH capsulatumi infection history showed patient recently traveled Bangladesh thought region endemic histoplasmosis case noteworthy disseminated histoplasmosis rarely affect immunocompetent individuals infectious etiology adrenal insufficiency exceedingly rare especially United States treatment regimen included 14day induction therapy IV amphotericin B followed outpatient itraconazole leading symptom resolution case highlight need consider infectious etiology adrenal insufficiency especially among immunocompetent individual may risk traveling endemic areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37868514/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37760732",
        "title": "Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus.",
        "abstract": "development potent antiviral agent utmost importance combat global burden viral infections Traditional antiviral drug development involves targeting specific viral proteins may lead emergence resistant strains explore alternative strategies investigated antiviral potential antimicrobial peptidomimetic compounds study evaluated antiviral potential 17 short anthranilamidebased peptidomimetic compound two viruses Murine hepatitis virus 1 MHV1 surrogate human coronaviruses herpes simplex virus 1 HSV1 halfmaximal inhibitory concentration ICsub50sub value compound determined vitro assess potency antiviral agents Compounds b11b b14b displayed potent inhibitory effect ICsub50sub value 238 μM 63 μM MHV1 compound b9b b14b showed ICsub50sub value 148 μM 13 μM HSV1 Multiple antiviral assessment microscopic image obtained transmission electron microscopy TEM collectively demonstrated compound exert direct influence viral envelope Based outcome concluded peptidomimetic compound could offer new approach development potent antiviral agents",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37760732/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37703339",
        "title": "The Role of Nonprofit and Nongovernmental Organizations and People With Viral Hepatitis on the Path Toward Hepatitis C Virus Elimination.",
        "abstract": "Nonprofit nongovernmental organization driven continue drive hepatitis C elimination putting people viral hepatitis affected community center hepatitis elimination efforts key driving decentralization service communitybased delivery hepatitis care pathway improve health wellbeing population affected hepatitis C article explores formation World Hepatitis Alliance WHA international network community organization 100 countries led powerful advocacy community leader people hepatitis resulting establishment World Hepatitis Day Since then World Health Organization WHO recognized importance viral hepatitis setting 2030 global elimination targets WHA collaborated 3 World Hepatitis Summits built momentum across many sector help elevate hepatitis global health agenda article discusses paradigmshifting campaign also present civil society organizations hepatitis elimination effort Egypt Mongolia Bangladesh United Kingdom significant impact local resource mobilization engagement national governments",
        "mesh_terms": [
            "Humans",
            "Hepacivirus",
            "Organizations, Nonprofit",
            "Hepatitis C",
            "Hepatitis A",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37703339/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37700968",
        "title": "Assessing Thrombocytopenia and Chronic Liver Disease in Southeast Asia: A Multicentric Cross-Sectional Study.",
        "abstract": "Background multicentric crosssectional study aimed examine prevalence thrombocytopenia TCP investigate various cause chronic liver disease CLD across 15 Southeast Asian India Pakistan Bangladesh tertiary care center threemonth period study focused assessing fibrosis index FI Model EndStage Liver Disease MELDsodium Na scores capacity grade predict progression outcome patient already diagnosed CLD Methods crosssectional study enrolled 377 CLD patients study utilized admission registry 15 tertiary care hospital Southeast Asia spanning April 2023 June 2023 Various descriptive variable collected including gender tobacco use specifically chewed tobacco underlying etiology presence anemia leukopenia pancytopenia infectious state liver cirrhosis diagnosed via traditional ultrasonography study examined liver failure indicators including alanine transaminase levels compensation status TCP liver transplant LT listing MELDNa score focus frequency percentage analysis MELDNa FI median standard deviation provided Results study 377 patient CLD found TCP present 4 patient leukopenia present 12 patients risk TCP significantly higher leukopenic patient 895 nonleukopenic patient 525 p  0003 common CLD cause undiagnosable 31 followed autoimmune 26 hepatitis C virus 21 hepatitis B virus 14 schistosomiasis 8 majority patient 98 decompensated liver disease patients 64 TCP 36 not illness severity indicator MELD score FI mean ± SD value 1689 ± 642 41 ± 106 respectively Similarly prevalence LT need among traditional ultrasonographydiagnosed cirrhotic patient 831 compared 596 among noncirrhotic patient p  0001 Conclusion Leukopenia TCP may linked may affect CLD treatment prognosis population Noninvasive indicator like FI MELDNa score detect liver fibrosis severity without invasive procedures enhancing patient management finding highlight need improve early diagnosis method CLD Southeast Asia raise awareness among clinician effective diagnostic strategy noninfectious cause CLD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37700968/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37697804",
        "title": "Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 <i>Salmonella</i> Typhi genomes.",
        "abstract": "Global Typhoid Genomics Consortium established bring together typhoid research community aggregate analyse iSalmonella entericai serovar Typhi Typhi genomic data inform public health action analysis mark 22 year since publication first Typhi genome represents largest Typhi genome sequence collection date n13000 metaanalysis global genotype antimicrobial resistance AMR determinant extracted previously sequenced genome data analysed using consistent method implemented open analysis platform GenoTyphi Pathogenwatch Compared previous global snapshots data highlight genotype 431 H58 spread beyond Asia EasternSouthern Africa regions distinct genotype dominate independently evolved AMR Data gap remain many part world show potential travelassociated sequence provide informal sentinel surveillance locations data indicate ciprofloxacin nonsusceptibility 1 resistance determinant widespread across geography genotypes highlevel ciprofloxacin resistance ≥3 determinants reaching 20 prevalence South Asia Extensively drugresistant XDR typhoid become dominant Pakistan 70 2020 yet become established elsewhere Ceftriaxone resistance emerged eight nonXDR genotypes including ciprofloxacinresistant lineage 43121 India Azithromycin resistance mutation detected low prevalence South Asia including two common ciprofloxacinresistant genotypes consortiums aim encourage continued data sharing collaboration monitor emergence global spread AMR Typhi inform decisionmaking around introduction typhoid conjugate vaccine TCVs prevention control strategies specific funding awarded metaanalysis Coordinators supported fellowship European Union ZAD received funding European Unions Horizon 2020 research innovation programme Marie SklodowskaCurie grant agreement 845681 Wellcome Trust SB Wellcome Trust Senior Fellowship National Health Medical Research Council DJI supported NHMRC Investigator Grant GNT1195210",
        "mesh_terms": [
            "Humans",
            "Salmonella typhi",
            "Typhoid Fever",
            "Anti-Bacterial Agents",
            "Travel",
            "Drug Resistance, Bacterial",
            "Ciprofloxacin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37697804/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37601374",
        "title": "Corrigendum: Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment.",
        "abstract": "This corrects article DOI 103389fmicb2021780887",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37601374/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37565062",
        "title": "Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh.",
        "abstract": "Hepatitis C virus HCV causative agent cause chronic liver disease worldwide little enclosed singlestranded ribonucleic acid RNA virus recognition pathogenic HCV genotype critical remedy sufferers aim study identify HCV RNA genotype decide correct treatment hepatitis C positive sufferer Bangladesh Blood sample collected 390 individual isolated RNA 60 µg blood plasma Extracted RNA used quantitative HCV RNA complementary DNA cDNA prepared polymerase chain reaction PCR conducted reverse transcriptase enzyme cDNA amplified multiplex RTPCR performed specific set primers HCV RNA genotype detected 297 390 patients 390 test samples 200 5128 sample male 190 4871 females age ranging 5 78 years all 166 200 male sample 131190 female sample found positive HCV 390 participant included study 213 5461 identified genotype 3 positive 78 20 genotype 1 positive 6 153 genotype 6 positive remaining 93 2385 sample unclassified due lowundetected viral load study detected highest percentage 3089 genotype 3 HCV patient aged 51 60 years result suggested genotype 3 HCV frequently present Bangladesh usually response better interferon therapy However genotype 1 6 HCV also found circulating country demand longer treatment effective control measures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37565062/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37525798",
        "title": "Evaluation and Determination of Quantitative Hepatitis B Surface Antigen Diagnostic Performance in Chronic Hepatitis B Virus-Infected Patients.",
        "abstract": "Background Hepatitis B virus DNA HBVDNA assessment recommended diagnosing monitoring chronic hepatitis B CHB patients Quantitative hepatitis B surface antigen qHBsAg estimation adjunct HBVDNA vital assessing HBV chronicity therapeutic prognosis study aimed estimate qHBsAg compare diagnostic performance HBVDNA level CHB patient Bangladesh Methodology total 148 CHB patient enrolled study qHBsAg hepatitis B eantigen HBeAg estimated using chemiluminescent enzyme immunoassays respectively HBVDNA quantified using realtime polymerase chain reaction parameter diagnostic performance analyzed receiver operating characteristic ROC curve analysis Results overall level mean ± SD qHBsAg HBVDNA alanine aminotransferase ALT among total population n  148 345 ± 080 logsub10sub IUmL 440 ± 244 logsub10sub IUmL 8617 ± 3906 IUL respectively Significant difference observed level qHBsAg p  0004 HBVDNA p  00001 case HBeAg positivity qHBsAg level showed weak positive correlation level HBVDNA ALT HBeAgpositive CHB patients relationship observed HBeAgnegative CHB patients ROC curve analysis showed area curve qHBsAg level distinguish high HBVDNA level 5 logsub10sub IUmL 0653 p  0002 indicated acceptable diagnostic performance best cutoff qHBsAg predicting high HBVDNA level 3469 logsub10sub IUmL Conclusions result indicated qHBsAg might useful marker monitoring HBVDNA CHB patient throughout treatment followup",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37525798/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37509583",
        "title": "Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection.",
        "abstract": "According World Health Organization WHO estimated 296 million people chronically infected hepatitis B virus HBV Approximately 1525 people develop complication advanced chronic liver disease ACLDs Mortality due HBVrelated complication accounted estimated 882000 death 2019 Potent preventive vaccine already restricted new HBV infections several drug available treat chronic HBV infections However positive impact drug recorded patient chronic HBV infection drug show longterm efficacy cannot halt progression complications Thus effective evidencebased therapeutic strategy need urgently developed patient chronic HBV infection CHB pathological entity induced HBV progress due impaired host immunity indicates inherent limitation antiviraldrugbased monotherapy treating patient chronic HBV infection Additionally commercially available antiviral drug available patient developing resourceconstrained countries posing challenge achieving following goal Elimination Hepatitis 2030 such review aimed provide insight regarding evidencebased effective management strategy chronic HBV infection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37509583/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "40636909",
        "title": "Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus infection.",
        "abstract": "Currently treatment oral directacting antiviral recommended hepatitis C virus HCVinfected pediatric patients aim study evaluate efficacy safety sofosbuvir ribavirin combination therapy child adolescent Bangladesh living chronic HCV infection experimental study performed January 2021 December 2022 HCV polymerase chain reaction PCRpositive thalassemic children 618 year age enrolled consecutive nonprobability sampling Clinical feature recorded investigation performed patient initially treated sofosbuvir 200 mg 6 11yearolds 400 mg 12 18yearolds ribavirin 1015 mgkgday assessed clinically fourweekly basis along liverfunction testing total duration therapy 24 weeks HCV PCR done end treatment 12 week completion treatment see sustained virological response 26 case total mean age 926 ± 282 years 14 male 538 12 female 462 Twentyfive 9615 patient achieved sustained virological response endoftreatment PCR negative One patient 385 nonresponder even 24 week treatment medication well received four patient 153 reporting headache reported untreated combination sofosbuvir ribavirin effective treating chronic HCV infection accompanied major negative side effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40636909/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37454777",
        "title": "The role of bixin as antioxidant, anti-inflammatory, anticancer, and skin protecting natural product extracted from Bixa orellana L.",
        "abstract": "Since long medicinal plant herb used different traditional treatment system therapeutic agent treat variety illnesses Bixa orellana L medicinal plant family Bixaceae Ayurvedic herb used treat dyslipidemia diarrhoea hepatitis since ancient times B orellana L seed contain orangered coloured component known bixin Csub25subHsub30subOsub4sub constitutes 80 extractChemically bixin natural apocarotenoid biosynthesized oxidative degradation C40 carotenoids Bixin help regulate Nrf2MyD88TLR4 TGF1PPARSmad3 pathways give antifibrosis antioxidant antiinflammatory properties current review article present comprehensive review bixin antiinflammatory antioxidant anticancerand skin protecting natural product addition biosynthesis molecular target bixin along bixin extraction techniques also presented",
        "mesh_terms": [
            "Antioxidants",
            "Bixaceae",
            "Biological Products",
            "Molecular Structure",
            "Carotenoids",
            "Anti-Inflammatory Agents",
            "Plants, Medicinal",
            "Plant Extracts"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37454777/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37427238",
        "title": "Liver injury: the therapeutic dilemma of homeopathy - a case report from Bangladesh.",
        "abstract": "Despite lack scientific evidence supporting effectiveness homeopathic treatment increasingly used form alternative medicine many people taking homeopathic remedy instead drug therapies based principle like cure like meaning remedy similar illness used treat it However several report suggesting risk homeopathic remedies among homeopathyinduced liver injury widely discussed Here report case 35yearold welloriented male patient typical clinical presentation liver injury presented yellowish discoloration sclera skin along generalized body itching following use homeopathic medicine musculoskeletal pain Laboratory report increased liver marker along bilirubin also suggestive Excluding differential like viral hepatitis alcoholic hepatitis hemochromatosis Wilson disease standard drug toxininduced hepatitis recent use homeopathic remedy contributing factor leading diagnosis homeopathyinduced liver injury treated discontinuation homeopathic medicine supportive care case highlight need public awareness possible complication headache tiredness skin eruption dizziness bowel dysfunction allergic reaction acute pancreatitis renal failure neurological dysfunction possible liver injury even mortality patient pursue homeopathic treatment health care professional take account making differential diagnosis patient liver injury",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37427238/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37425840",
        "title": "Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infants.",
        "abstract": "Hepatitis B virus HBV vaccine escape mutant VEM increasingly described threatening progress control virus worldwide studied relationship host genetic variation vaccine immunogenicity viral sequence implicating VEM emergence cohort 1096 Bangladeshi children identified human leukocyte antigen HLA variant associated response vaccine antigens Using HLA imputation panel 9448 south Asian individual iDPB10401i associated higher HBV antibody response p45×10sup30sup underlying mechanism result higher affinity binding HBV surface antigen epitope DPB10401 dimers likely result evolutionary pressure HBV surface antigen adeterminant segment incurring VEM specific HBV Prioritizing preS isoform HBV vaccine may tackle rise HBV vaccine evasion",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37425840/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37391960",
        "title": "Comparison of Serum Zinc in Children of Wilson Disease and Non-Wilsonian Volunteers in Bangladesh.",
        "abstract": "Wilson disease WD autosomal recessive disorder copper metabolism diverse clinical manifestations Zinc Zn used treatment WD Recent study showed low serum zinc level patient suffering WD normal crosssectional analytical study designed compare serum zinc level paediatric patient suffering WD yet started treatment child normal ALT level study carried Department Pediatric Gastroenterology Nutrition BSMMU Dhaka Bangladesh July 2018 June 2019 Total 51 child included study Among 27 diagnosed case WD aged three eighteen year 24 child age suffering liver disease normal ALT included volunteers patient WD divided four group according presentation acute hepatitis chronic liver disease CLD acute liver failure  neuropsychiatric manifestation Informed written consent obtained patient volunteer participation study Along physical finding laboratory investigation 3 ml venous blood collected estimation serum zinc level estimation serum zinc level result analyzed statistically difference serum zinc level compared groups Serum zinc level significantly lower Wilson disease patient 438±197μgdl range 1383 compared volunteer group 678±118μgdl range 4797 p0001 Among diseased group serum zinc level significantly lower 18 CLD 384±174μgdl 4 acute liver failure 331±37μgdl compared 4 acute hepatitis 718±43μgdl p0001 p0001 respectively Mean serum zinc level low 4 Wilsonian acute liver failure 331±37μgdl significant compared 23 presented Wilson disease non acute liver failure 457±208μgdl p0013 Serum zinc level significantly lower Wilson disease child compared volunteers Zinc level also found significantly low Wilson disease presented CLD acute liver failure comparison Wilson disease presented acute hepatitis",
        "mesh_terms": [
            "Humans",
            "Child",
            "Child, Preschool",
            "Adolescent",
            "Hepatolenticular Degeneration",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Liver Failure, Acute",
            "Volunteers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37391960/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37375532",
        "title": "Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking.",
        "abstract": "Hepatitis C virus HCV dangerous virus responsible large number infection death worldwide treatment HCV important drug effective additional hepatotoxic effects aim study test silico activity 1893 terpene HCV NS5B polymerase PDBID 3FQK Two drugs sofosbuvir dasabuvir used controls GOLD software CCDC InstaDock used docking using result obtained PLPFitness GOLD pKi binding free energy InstaDock nine terpene finally selected based scores druglikeness property calculated using Lipinskis rule five ADMET value studied using SwissADME pkCSM servers Ultimately shown nine terpene better docking result sofosbuvir dasabuvir gniditrin mulberrofuran G cochlearine A ingenol dibenzoate mulberrofuran G isogemichalcone C pawhuskin B 3cinnamyl4oxoretinoic acid DTXSID501019279 mezerein docked complex submitted 150 nslong molecular dynamic simulation ascertain binding stability result show mulberrofuran G cochlearine A stereoisomers pawhuskin B form stable interaction active site region reaction product form are therefore good candidate use effective competitive inhibitors compound identified docking screen either afford extremely weak or even hardly any binding such ingenol dibenzoate gniditrin mezerein must first undergo preliminary movement active site attaining stable binding conformations process may take 60 80 n for DTXSID501019279 3cinnamyl4oxoretinoic acid isogemichalcone C",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37375532/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37363565",
        "title": "Dreadful infectious disease outbreaks threaten flood-ravaged pakistan: short communication.",
        "abstract": "rise incidence waterborne communicable illnesses viral outbreak Pakistan follows period heavy rainfall Due climate change flood drought devastating effect human health facilitating spread infectious illness including cholera malaria typhoid dengue fever viral hepatitis A Food instability starvation malnutrition lack potable water indirect effect flooding health Recently one worst flood history devastated Pakistan affecting 333 million people along significant portion nation submerged Malaria dengue fever ailment rise Pakistan threatening overwhelm countrys healthcare infrastructure urgent need preventative measure Pakistan cope dreadful outbreaks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37363565/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37346467",
        "title": "Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology.",
        "abstract": "Chikungunya CHIK patient may vulnerable coronavirus disease COVID19 However presently antiCOVID19CHIK therapeutic alternative available purpose research determine pharmacological mechanism kaempferol function treatment COVID19associated CHIK coinfection used series network pharmacology computational analysisbased technique decipher define binding capacity biological functions pharmacological targets treatment process COVID19mediated CHIK coinfection identified key therapeutic target COVID19CHIK including TP53 MAPK1 MAPK3 MAPK8 TNF IL6 NFKB1 Gene ontology molecular upstream pathway analysis kaempferol COVID19 CHIK showed DEGs confined mainly cytokinemediated signalling pathway MAP kinase activity negative regulation apoptotic process lipid atherosclerosis TNF signalling pathway hepatitis B tolllike receptor signaling IL17 IL18 signaling pathways study gene regulatory network revealed several significant TFs including KLF16 GATA2 YY1 FOXC1 miRNAs let7b5p mir165p mir34a5p mir1555p target differentialexpressed gene DEG According molecular coupling results kaempferol exhibited high affinity 5 receptor protein TP53 MAPK1 MAPK3 MAPK8 TNF compared control inhibitors combination result identified significant target pharmacological mechanism kaempferol treatment COVID19CHIK recommended core target used potential biomarkers COVID19CHIK viruses conducting clinical study intervention COVID19 CHIK kaempferol might evaluated wet lab test molecular level",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37346467/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37298575",
        "title": "Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview.",
        "abstract": "Tolllike receptor TLRs evolutionarily conserved pattern recognition receptor play important role early detection pathogenassociated molecular pattern shaping innate adaptive immune responses may influence consequence infection Similarly viral infections human immunodeficiency virus type 1 HIV1 also modulates host TLR response therefore proper understanding response induced human HIV1 coinfection hepatitis B virus HBV hepatitis C virus HCV due common mode transmission viruses essential understanding HIV1 pathogenesis mono coinfection HBV HCV well HIV1 cure strategies review discus host TLR response HIV1 infection innate immune evasion mechanism adopted HIV1 infection establishment also examine change host TLR response HIV1 coinfection HBV HCV however type study extremely scarce Moreover discus study investigating TLR agonist latencyreverting agent immune stimulators towards new strategy curing HIV understanding help develop new strategy curing HIV1 monoinfection coinfection HBV HCV",
        "mesh_terms": [
            "Humans",
            "HIV-1",
            "Coinfection",
            "Hepatitis B",
            "Hepatitis B virus",
            "Toll-Like Receptors",
            "Hepatitis C",
            "Hepacivirus",
            "HIV Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37298575/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37286539",
        "title": "A high-throughput test enables specific detection of hepatocellular carcinoma.",
        "abstract": "Highthroughput test early cancer detection revolutionize public health reduce cancer morbidity mortality show DNA methylation signature hepatocellular carcinoma HCC detection liquid biopsies distinct normal tissue blood profiles developed classifier using four CpG sites validated TCGA HCC data single F12 gene CpG site effectively differentiates HCC sample blood samples normal tissues nonHCC tumor TCGA GEO data repositories marker validated separate plasma sample dataset HCC patient controls designed highthroughput assay using nextgeneration sequencing multiplexing techniques analyzing plasma sample 554 clinical study participants including HCC patients nonHCC cancers chronic hepatitis B healthy controls HCC detection sensitivity 845 95 specificity 094 AUC Implementing assay highrisk individual could significantly decrease HCC morbidity mortality",
        "mesh_terms": [
            "Carcinoma, Hepatocellular",
            "Liver Neoplasms",
            "Liver",
            "DNA Methylation",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37286539/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37243066",
        "title": "Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon.",
        "abstract": "openlevel randomized treatmentcontrolled clinical trial shown therapeutic vaccine containing hepatitis B surface antigen HBsAg hepatitis B core antigen HBcAg NASVAC endowed antiviral liver protecting capacity safer pegylated interferon PegIFN patient chronic hepatitis B CHB present study provides information role hepatitis B virus HBV genotype phase III clinical trial total 160 patient enrolled trial HBV genotype 133 patient characterized NASVAC induced stronger antiviral effect HBV DNA reduction 250 copy per mL PegIFN antiviral effect alanine aminotransferase level significantly different among different HBV genotype NASVACtreated patients However significantly higher proportion genotypeD patient receiving NASVAC showed better therapeutic effects compared genotypeD patient receiving PegIFN marked difference 44 conclusion NASVAC seems better alternative PegIFN especially patient HBV genotypeD patients reflects attractiveness NASVAC country genotype highly prevalent mechanism underlying effect HBV genotype studied new clinical trial",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37243066/",
        "source_type": "Bangladesh-specific"
    },
    {
        "pmid": "37007026",
        "title": "Emerging mechanistic insights of selective autophagy in hepatic diseases.",
        "abstract": "Macroautophagy hereafter referred autophagy highly conserved metabolic process regulates cellular homeostasis degrading dysfunctional cytosolic constituent invading pathogen iviai lysosomal system addition autophagy selectively recycles specific organelle damaged mitochondrion iviai mitophagy lipid droplet LDs iviai lipophagy eliminates specialized intracellular pathogenic microorganism hepatitis B virus HBV coronaviruses iviai virophagy Selective autophagy particularly mitophagy play key role preservation healthy liver physiology dysfunction connected pathogenesis wide variety liver diseases example lipophagy emerged defensive mechanism chronic liver diseases prominent role mitophagy lipophagy hepatic pathology including nonalcoholic fatty liver disease NAFLD hepatocellular carcinoma HCC druginduced liver injury Moreover selective autophagy pathway including virophagy investigated context viral hepatitis and recently coronavirus disease 2019 COVID19associated hepatic pathologies interplay diverse type selective autophagy impact liver disease briefly addressed Thus modulating selective autophagy eg mitophagy would seem effective improving liver diseases Considering prominence selective autophagy liver physiology review summarizes current understanding molecular mechanism function selective autophagy mainly mitophagy lipophagy liver physiology pathophysiology may help finding therapeutic intervention targeting hepatic disease iviai manipulation selective autophagy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37007026/",
        "source_type": "Bangladesh-specific"
    }
]